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ABSTRACT OF THE DISSERTATION
The RpL13a snoRNA U33 Forms Novel snoRNPs During Lipotoxicity
by
Miquia Sherree Henderson
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular and Cell Biology
Washington University in St. Louis, 2017
Professor Jean Shaffer, Chair
Lipid overload contributes to the pathogenesis of diabetic complications, causing tissue
damage and cell death in a number of organ systems. This process is termed
lipotoxicity. Animal and cell culture studies have demonstrated that oxidative stress and
endoplasmic reticulum stress are major pathways engaged in the lipotoxic response.
However, the molecular mechanisms of lipotoxicity are not well understood. A genetic
screen revealed that small nucleolar RNAs (snoRNAs) encoded in the introns of the
Rpl13a locus are critical for cell death in response to lipotoxicity. Initial studies have
suggested that the Rpl13a snoRNAs function in this pathway through non-canonical
modes of action, involving trafficking to the cytoplasm.

To gain insight into the mechanism of action of Rpl13a snoRNA U33, snoRNPs were
isolated from cells. We observed many previously undescribed snoRNA-interacting
proteins in whole cell lysates. Identification of proteins that co-precipitate from cytosolic
and post-cytosolic lysates, under lipotoxic stress and basal conditions, demonstrated
that U33-containing complexes are dynamic, and the composition of these complexes

viii

depends on both subcellular localization and the presence or absence of stress. We
hypothesized that Rpl13a snoRNAs may direct modification of cytosolic mRNAs to
affect their abundance or translation efficiency. Consistent with this model, RNA-seq
analysis identified over 200 transcripts with significant changes in abundance under
lipotoxic conditions. Metabolic labeling revealed that many of these changes are due, at
least in part, to changes in transcript stability. Furthermore, ribosome footprinting
indicated that a number of transcripts are differentially translated during lipotoxicity.
Together, these studies add to a growing body of evidence that snoRNAs function in
roles beyond the processing and modification of ribosomal RNAs.
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Chapter 1
Introduction
1.1 Lipotoxicity in Disease
Nearly 30 million adults in the United States have diabetes, with another 87 million
estimated to have prediabetes.1 The majority of these individuals have type 2 diabetes.
The rise in disease prevalence in recent years is likely to be related to the alarming rise
in rates of obesity, which is associated with hyperlipidemia and insulin resistance.2-7
Diabetes poses an enormous burden on our health care system, with estimated annual
medical costs of $176 billion.1 Beyond treatment of the primary metabolic abnormalities
of diabetes, patients require care for the many complications of the disease that impact
the eye, kidney, heart and vascular system, reproductive function, and nervous system.
Cardiovascular disease is the most common cause of death among patients with
diabetes,8 who have a 2.4- to 5-fold increased risk of heart failure9 and a 2-4-fold
increased risk of atherosclerosis.10 Further, diseases of the cardiovascular system are
more aggressive in diabetics, who have an increased risk of morbidity and mortality
following myocardial infarction.11,12

Patients with type 2 diabetes frequently have elevated fasting serum triglycerides13 and
elevated post-prandial serum triglycerides,14 in addition to alterations in lipoprotein
levels and serum glucose abnormalities, which contribute to many disease
complications. When triglycerides and free fatty acids (FFAs) exceed adipose tissue
1

storage capacity, or when lipolysis in adipose tissues is dysregulated, such as occurs in
insulin resistance, the excess lipid presented to non-adipose tissues results in uptake in
excess of the capacity of these tissues to metabolize the lipid.15-18 Patients with type 2
diabetes have evidence for increased triglyceride accumulation in the heart, skeletal
muscle, liver, and pancreas.19-22

Accumulation of excess lipid is associated with organ dysfunction. Roger Unger coined
the term “lipotoxicity” to describe the untoward consequences of ectopic lipid
accumulation.23 In his studies of the Zucker diabetic fatty rat (ZDF), pancreata of obese
animals had decreased glucose-stimulated insulin secretion.24 The ZDF rats showed
significant amounts of myocardial triglyceride relative to lean controls and had
significant cardiac dysfunction, as indicated by increased end diastolic left ventricular
diameter and decreased fractional shortening measured by echocardiogram.25 Lipidinduced cardiac dysfunction has also been studied in a number of transgenic mouse
models in which overexpression of lipid transport proteins in cardiac myocytes drives
excessive lipid uptake despite normal serum lipid levels.26-28 In human subjects, excess
lipid accumulation in the heart is also associated with cardiac dysfunction.29
Furthermore, exposure of skeletal muscle to excess lipid is associated with insulin
resistance in human subjects.30,31 Collectively, these studies suggest an important role
for lipid overload in the pathogenesis of diabetes and its complications.

2

1.2 Molecular Mechanisms of Lipotoxicity
Initial understanding of the molecular mechanisms that underlie lipotoxicity has come
from cell culture studies in which the media is supplemented with 500µM – 1mM
saturated fatty acid (e.g. palmitate) complexed to albumin for 24-72 hours to model
pathophysiological lipid excess. Saturated long chain fatty acids are not efficiently
incorporated into triglyceride pools, but rather are rapidly incorporated into
phospholipids, leading to significantly increased saturation of membrane lipids in the
endoplasmic reticulum and diminished cardiolipin content of mitochondria.32,33
Ultrastructural studies have revealed significant changes in the ER morphology of
palmitate treated cells, resulting in marked distention of the rough ER in Chinese
hamster ovary (CHO) cells and aggregation plus abnormal distribution of the ER in INS1 immortalized pancreatic beta cells.32,34 Lipotoxicity alters ER integrity, as evidenced
by release of calcium from the ER and the detection of luminal proteins GRP78 and PDI
in the cytosolic fraction of CHO cells following palmitate treatment.32 Furthermore,
saturated lipid overload induces ER stress, as evidenced by the increased splicing of
XBP-1, phosphorylation of PERK, and induction of the transcription factor CHOP.34

Palmitate treatment also results in significant accumulation of reactive oxygen species
(ROS).35,36 Lipotoxic stress induces free radical production in cultured aortic smooth
muscle cells as measured by electronic spin resonance.37 Inhibition of this ROS
production by an NADPH oxidase inhibitor suggests that superoxide may be an
important species of free radical in this system. Palmitate treatment of cultured Chinese
hamster ovary cells leads to increased ROS as detected by dichlorodihydrofluorescein
3

diacetate that can be attenuated with dihydroxy-1,3-benzene-disulfonic acid (DBDA) or
pyrrolidine dithiocarbamate (PDTC), agents known to have antioxidant effects.35 Cotreatment of cells with DBDA or PDTC during lipotoxicity blocks induction of caspase 3
activity and DNA laddering, indicating a causative role for oxidative stress in the
apoptotic response to lipotoxicity.35 However, the antioxidant tocopheral did not
abrogate changes in ER morphology with palmitate treatment, even though the amount
of ROS was significantly inhibited, indicating that some lipotoxic effects on the ER are
independent of ROS.32

While treatment with saturated long-chain fatty acids has been shown to have
deleterious effects, treatment with unsaturated long-chain fatty acids (e.g. oleate) is
protective. Oleate does not induce ROS, alterations in ER morphology or membrane
integrity, or apoptosis.32,35,38,39 Remarkably, while exposure to saturated fatty acids
results in the death of cultured neonatal cardiomyocytes and rat b-cells, co-treatment
with equimolar amounts of unsaturated fatty acids rescues the cells from apoptosis.35,36
The observations that excessive saturated fatty acids are particularly toxic suggests that
saturated and unsaturated fatty acids may turn on different molecular pathways when
they are present in excess.

In order to further elucidate the molecular mechanism of lipotoxicity, the Schaffer lab
performed a genetic screen to identify critical mediators of lipotoxicity in CHO cells.
CHO cells are fibroblasts that are sensitive to palmitate-induced cell death and wellsuited to genetic screens because they are genetically diploid.40,41 CHO cells were
4

transduced with a ROSAbgeo retroviral promoter trap at a low multiplicity of infection to
obtain an average of less than 1 insertion event per ten cells.36 The integrated provirus
contains a neomycin resistance cassette, but lacks its own promoter. Thus, the
antibiotic resistance gene encoded within the provirus will not be expressed unless the
integration occurs in close proximity to an actively transcribed RNA polymerase II
promoter. Following selection with neomycin for 48 hours, only mutant cells in which a
promoter is trapped, and hence a gene is disrupted, should survive. Mutants were then
selected by growth in media containing 500 µM palmitate for 48 hours. This treatment is
lethal to wild type cells, and mutants that survived were likely to contain an insertion in a
gene critical to the lipotoxic response. 5’-RACE was used to identify the disrupted
genes, and genetic validation experiments were performed to confirm the roles of the
disrupted genes in lipotoxicity.36,42,43

1.3 Identification of snoRNAs as mediators of
lipotoxicity
The Rpl13a gene was identified as the insertion site in the 6F2 mutant, which was
resistant to palmitate-induced cell death but not general inducers of cell death.42 This
locus encodes the RPL13a protein, a component of the large ribosomal subunit, and
four intronic C/D box small nucleolar RNAs (snoRNAs), U32a, U33, U34, and U35a.
Although the mutant cells were complemented with the genomic Rpl13a sequence,
restoring palmitate sensitivity, the cDNA sequence did not complement the mutant.
Furthermore, knockdown of the mRNA in wild type cells did not confer palmitate
resistance, whereas knockdown of at least three of the Rpl13a snoRNAs in wild type
5

cells resulted in palmitate resistance. These findings indicate that the Rpl13a snoRNAs
are critical mediators of lipotoxicity. This was the first study to suggest a role for
snoRNAs in the response to metabolic stress.

1.4 Small Nucleolar RNAs
SnoRNAs are non-coding RNAs, typically 70 to 150 nucleotides in length, named for
their primary location in the nucleolus. Two main classes of snoRNAs have been
described – H/ACA box and C/D box – which are distinguished based on conserved
sequence elements. H/ACA snoRNAs contain two hairpin structures separated by a
single-stranded hinge region containing the H box motif (consensus sequence
ANANNA).44 The ACA box motif is located three nucleotides from the 3’-end of the
RNA.45 C/D box snoRNAs contain a single k-turn motif that separates the conserved C
box (UGAUGA) and D box (CUGA) sequence elements.46 Most metazoan snoRNAs are
intron-encoded, often in housekeeping genes.47-50 A small number are independently
transcribed by RNA polymerase II and subsequently modified with a trimethylguanosine
cap at the 5’ end.46,51 Intronic snoRNAs are processed from pre-mRNAs, predominantly
by exonucleolytic trimming of excised, debranched introns.52,53 C/D box snoRNAs are
found 70-80 nucleotides upstream of the 3’ splice site, a location that is critical for
efficient snoRNA production.54 On the other hand, location of intronic H/ACA snoRNAs
relative to the 3’ splice site is more permissive.55 For both snoRNA classes, the
conserved sequence elements in their respective boxes are required for metabolic
stability and proper snoRNA processing.56-59
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snoRNAs interact with a number of proteins transiently. The proteins Naf1p and Shq1p
are assembly factors that mimic molecules that H/ACA snoRNAs will later associate
with (proteins and RNA) to prevent nonspecific interactions.60,61 H/ACA snoRNP
assembly occurs during or shortly after transcription, and is an independent molecular
event from splicing of the host transcript.55,62 The proteins BCD1, Pih1/Nop17, Taf9,
Nufip, Rvb1/Tip49, and Rvb2/Tip48 associate with C/D box snoRNA precursors and are
believed to play a role in snoRNP assembly.63,64 Nufip and hsp90 both act as scaffolds
or chaperones to promote interactions between snoRNAs and other assembly
factors.65,66 The R2TP complex, composed of Rvb1, Rvb2, Tah1, and Pih1, is required
for the final assembly of the mature C/D snoRNP complex.65

Each snoRNA class ultimately forms a canonical mature/core snoRNP complex
containing four unique proteins. H/ACA snoRNAs associate with the core proteins
Nhp2, Nop10, Gar1, and dyskerin.67-69 Core C/D box snoRNPs contain the proteins
15.5K, Nop56, Nop58, and fibrillarin.46,47,70,71 Protein 15.5K is the first core snoRNP
component to bind the RNA and initially associates during splicing; this binding is
required for accumulation of the remaining snoRNP proteins.72 Recent findings indicate
that Nop58 also binds the snoRNA early in snoRNP biogenesis, recruiting the R2TP
complex and allowing association of the remaining core proteins.73 Nop58 and 15.5K
are required for normal C/D box snoRNA accumulation, while all four core C/D box
snoRNP subunits are required for localization within the nucleolus.71,74,75

7

Although snoRNAs predominantly reside in the nucleolus, transcription and assembly
occur outside of this subnuclear compartment. Mammalian snoRNAs are primarily
transcribed as part of a longer pre-mRNA by RNA polymerase II in the nucleoplasm,
and snoRNA precursors are excluded from the nucleolus.76 snoRNP assembly may
begin in nucleoplasmic splicing speckles, as 15.5K binding to C/D box snoRNAs is
splicing-dependent and occurs before release of the intron lariat from the pre-mRNA;
furthermore, 15.5K has been shown to transiently localize to splicing speckles before
entering the nucleolus.72,77 C/D box snoRNAs transit through Cajal bodies, where they
likely interact with Nopp140 and undergo final processing steps.74 Although endogenous
H/ACA snoRNAs have not been detected in Cajal bodies, overexpressed U64 can be
detected in Cajal bodies, raising the possibility that H/ACA snoRNAs rapidly transit this
region en route to the nucleolus.78

Each snoRNA contains an antisense element that acts as a molecular zipcode, guiding
the entire snoRNP to a specific location on its target RNA by classical Watson-Crick
base pairing. Most characterized snoRNAs direct chemical modification of rRNA targets,
while a small number (including U3, U14, U8, and U17) act as molecular chaperones to
direct ribosomal RNA (rRNA) folding or cleavage events.79-82 Whereas H/ACA snoRNAs
direct pseudouridylation of their targets, catalyzed by the pseudouridine synthase
dyskerin,83 box C/D snoRNAs direct 2’-O-methylation. The antisense elements of C/D
box snoRNAs that base pair with their targets range from 10-21 nucleotides in length
and are located immediately upstream of the D (or D’) box motif.84 Most C/D box
snoRNAs direct the methyltransferase fibrillarin to perform 2’-O-methylation of the target
8

at the nucleotide bound five nucleotides upstream of the D box.84,85 Genetic
manipulation of the U20 antisense element sequence demonstrated that base-pairing
mismatches with the rRNA target were poorly tolerated, in some cases abolishing
methylation.86 Although no single rRNA chemical modification is required, complete
loss-of-function by knockout of fibrillarin causes collective loss of all 2’-O-methylations
and is lethal.87,88

An additional category of noncoding RNAs that localize to Cajal bodies in mature RNPs
has been identified, termed scaRNAs. These RNAs contain one or two C/D box or
H/ACA motifs, with most containing one of each.89 H/ACA scaRNAs contain an
additional sequence motif, the CAB box (consensus sequence ugAG), which is required
for Cajal body localization.78 C/D box scaRNAs also contain a Cajal body localization
motif, termed the GU/UG wobble stem and made up of dinucleotide repeats in the
terminal stem-loop of the apical hairpin.90 scaRNAs form RNPs with the canonical
snoRNP core subunits and direct chemical modification of the spliceosomal small
nuclear RNAs (snRNAs).89,91

1.5 Non-canonical Functions of snoRNAs and
implications for lipotoxicity
Mammalian cells contain over 300 known snoRNAs. While many snoRNAs have known
2’-O-methylation or pseudouridylation targets or have been shown to participate in
rRNA processing, many others are considered “orphans” with no known target or
9

function. The C/D box snoRNA HBII-52 was recently shown to lack complementarity to
rRNA and snRNA. Instead, its 18-nucleotide-long antisense element is complementary
to the serotonin receptor 2C pre-mRNA.92 The mouse homolog, MBII-52, is essential for
correct alternative splicing of this pre-mRNA and can form complexes with the proteins
nucleolin and ELAVL1.93,94 Further, MBII-52 localizes to both the nucleolus and the
nucleoplasm, while canonical snoRNAs are only found in the nucleolus.94 While MBII-52
is thought to directly impact alternative splicing, the scaRNAs may indirectly influence
alternative splicing by directing the chemical modification of the spliceosomal snRNAs.
A small percentage of human ACA45 is processed into a microRNA that targets the
3’UTR of Cdc2l6 mRNA, while Giardia lamblia miR2 is derived from a C/D box snoRNA
and modulates translation of a reporter with miR2 target sites in the 3’-UTR.95,96 These
studies indicate that snoRNAs can perform many unanticipated functions, and perhaps
additional roles have yet to be identified.

While the snoRNAs encoded within the Rpl13a locus are known to have rRNA targets,
previous work in the Schaffer lab suggests that the Rpl13a box C/D snoRNAs also
function non-canonically.42 Although each of the snoRNAs has an antisense element
with complementarity to rRNA, primer extension analysis has shown that the ribosomal
targets are not differentially modified in the haploinsufficient 6F2 mutant. Furthermore,
these rRNA targets are not differentially modified in wild type or 6F2 mutant cells under
lipotoxic conditions.42 In situ hybridization showed significant accumulation of the
Rpl13a snoRNAs in the cytosol following palmitate treatment.42 RTqPCR performed on
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subcellular fractions showed a similar result.97,98 Collectively, these studies suggest that
the Rpl13a snoRNAs are likely to play a non-canonical role in lipotoxicity.

Although mature snoRNPs have canonically been thought to reside in the nucleolus,
there is much evidence that snoRNAs may have a role outside the nucleus. In addition
to the above studies indicating that snoRNAs can be processed to miRNAs, Baserga et
al. found that cells possess a distinct mechanism for nuclear import of snoRNAs from
the cytoplasm,99 suggesting that snoRNAs may shuttle between the two compartments.
Serum starvation caused the U3 snoRNP to accumulate in the cytoplasm,100 consistent
with regulation of snoRNA function by changes in localization and thus proximity to its
target. U8 associates with the mRNA export protein PHAX and the snRNA import
protein Snuportin.101 Additionally, recent results have indicated that a large number of
snoRNAs accumulate in the cytosol in response to doxorubicin, a chemotherapeutic that
induces oxidative stress.102

Localization of snoRNAs in the cytoplasm suggests that non-canonical targets may
include mRNAs. Two early studies provided support for the notion that chemical
modification of mRNAs may be directed by snoRNAs. An engineered H/ACA snoRNA
was able to direct pseudouridylation of a reporter construct, disrupting a premature
termination codon and inducing the activity of the reporter protein.103 Similar results
were found when C/D box snoRNA U20 was modified to direct 2’-O-methylation of an
exogenous RNA polymerase II-transcribed target; this resulted in differential digestion of
the target by RNase T1, indicative of an increase in methylation when the RNAs were
11

co-expressed.86 More recently, evidence for snoRNA-directed modifications of
endogenous RNAs has come from “pseudouridine-seq” approaches. These studies
have shown that human and yeast mRNAs contain pseudouridines that are dependent
on the activity of dyskerin or its yeast homolog, Cbf5p.104-106 These studies support the
notion that snoRNAs may have non-canonical functions in the modification of mRNAs.

1.6 Concluding Remarks
Hyperlipidemia is a hallmark of obesity and type 2 diabetes mellitus. Increased
circulating lipids result in increased lipid uptake by non-adipose tissues, in which these
lipids have damaging effects. Genetic studies have demonstrated that the Rpl13a
snoRNAs are critical mediators of lipotoxicity, likely by a non-canonical mechanism. We
hypothesized that identification of the RNP components of these snoRNAs would
provide insights into their molecular role in lipotoxicity. Our studies demonstrate that
U33 interacts with previously undescribed proteins. These interactions are dynamic and
depend on subcellular localization and the presence/absence of metabolic stress.
Accumulation of snoRNPs in the cytoplasm places the snoRNAs in a compartment in
which abundant mRNAs may serve as targets. Therefore, we further hypothesized that
the Rpl13a snoRNAs accumulate in the cytosol during lipotoxicity to direct modification
of mRNAs, leading to changes in mRNA abundance and/or translation efficiency. Using
RNAseq analysis and ribosome footprinting, we found changes in both mRNA
abundance and translation efficiency of some transcripts under lipotoxic conditions.
Together, these experiments provide new insights into the molecular events of
lipotoxicity.
12

Chapter 2
U33-associated Proteins
2.1 Introduction
Box C/D snoRNAs are known to form a core snoRNP with the proteins fibrillarin, Nop56,
Nop58, and 15.5K. Other proteins have been shown to interact with C/D box snoRNAs,
but these proteins are not considered part of the core snoRNP. Several proteins,
including phosphorylated adapter RNA export protein (PHAX), Nopp140, TIP48, TIP49,
BCD1, and survival of motor neurons (SMN), have been implicated in snoRNP
biogenesis.64,76,107-110 The non-canonical C/D box snoRNA MBII-52 was reported to
associate with 17 proteins, many of which had not previously been described as
snoRNP components and which may be involved in the alternative splicing of the
serotonin receptor 2C transcript.94 In this chapter, we report a method for identification
of U33-interacting proteins from subcellular compartments of palmitate-treated cells. We
validated interactions between U33 and each of four proteins in the cytosol during
lipotoxicity. These results indicate that U33 interacts with previously undescribed
proteins, some of which may have roles in the non-canonical function of U33 in the
cytosol.

2.2 Results
In order to isolate endogenous U33 snoRNPs using an antisense oligo, we first
identified regions of U33 that are available for binding under conditions that preserve
13

interactions between snoRNAs and associated proteins in the snoRNP. In an approach
analogous to that used to identify available regions of snoRNAs U8 and U13,111 RNase
H digests were performed in the presence of antisense oligos directed against U33.
Complementary oligos were designed against six regions tiled along the length of U33
(Fig. 2.1A). Following sonication of cells in a mild buffer containing physiological
concentrations of NaCl and 0.05% of the non-ionic detergent NP-40, aliquots of cell
sonicate were incubated with RNase H and a single oligo. Reactions containing no
oligo served as negative controls. RNA was extracted with phenol:chloroform and
quantified by RTqPCR using a stem-loop primer for reverse transcription that was
complementary to the extreme 3’ end of the snoRNA and a forward PCR primer
complementary to the extreme 5’ end of the snoRNA.42,112 With this strategy, RTqPCR
detects intact U33, but any digestion along the length of the snoRNA precludes
detection.

Oligos tiled along the length of U33 resulted in different degrees of preservation of the
full length U33. Following digestion in the presence of oligos 2, 5, or 6, more than 50%
of U33 was degraded (Fig. 2.1B). However, U33 remained intact after digestion in the
presence of oligos 1, 3, or 4 as compared to when no oligo was present. This result
suggested that the regions complementary to oligos 2, 5, and 6 are available for binding
to an antisense oligo. By contrast oligos 1, 3, and 4 are likely complementary to regions
inaccessible due to secondary structure of the RNA and/or interactions between the
RNA and proteins in the snoRNP. Therefore, an antisense oligo (ASO) complimentary
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to U33 nucleotides 54-73, with biotin moieties at the 5’- and 3’-ends, was designed to
isolate endogenous U33 snoRNPs.

The schematic in Figure 2.2A depicts the ASO-mediated pull-down method to isolate
U33 snoRNPs from whole cell sonicates. Following sonication of cells, biotinylated oligo
was incubated with the sonicate to allow duplex formation with U33. Oligo-U33 snoRNP
complexes were then captured with high capacity streptavidin beads. Pull-downs were
performed in parallel with a sense oligo from the same region of U33, which served as a
negative control.

Pull-downs were analyzed for both RNA and protein recovery, comparing specific
recovery with the ASO to non-specific background with the sense oligo. RTqPCR
analysis of recovered RNA showed that U33 was enriched by over 150-fold by ASO
pull-down in comparison to sense oligo pull-down (Fig. 2.2B). On the other hand,
neither C/D box snoRNA U20 nor H/ACA box snoRNA U17b was significantly enriched
by U33 ASO pull-down. Western blot of co-precipitating protein confirmed that canonical
C/D box snoRNP core proteins Nop58 and fibrillarin were recovered in pull-downs using
ASO but not in sense oligo pull-downs, as would be expected for U33 snoRNP proteins
(Fig. 2.2C). These findings indicate that U33 ASO pull-down specifically isolated the
U33 snoRNA without disrupting association of two expected snoRNP proteins.
While pull-down followed by western blot confirmed association of U33 with canonical
C/D box snoRNP proteins, the role of the Rpl13a snoRNAs in lipotoxicity suggests that
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U33 might also interact with noncanonical proteins. In order to determine whether ASOmediated pull-down of U33 captured additional proteins besides the four canonical core
snoRNP proteins, pull-down of U33 from whole cell sonicates was repeated. Rather
than probe for specific proteins by western blot, co-precipitating proteins were
separated by gel electrophoresis and visualized with the fluorescent stain SYPRO Ruby
(Fig. 2.3A). The ASO pull-down lane contained many additional bands that were not
present in the sense pull-down lane, and many bands present in both lanes were
considerably more intense in the ASO lane. This result suggested that U33 might
associate with proteins not previously described as snoRNP components. Bands that
appeared similar in both ASO and sense pull-downs are likely to include proteins that
are non-specifically recovered with this approach.

Protein from ASO and sense pull-downs was in-solution digested, and peptides were
analyzed by liquid chromatography/mass spectrometry (LC/MS). Proteins with a
minimum of 2 peptides in the ASO pull-down and a 2:1 ratio of peptides detected in
ASO versus sense pull-down in two independent replicates were considered enriched
by the U33 ASO oligo (Table 2.1). While the canonical core C/D box snoRNP proteins
fibrillarin and Nop58 were found to associate with U33, we did not detect Nop56 or
15.5K, suggesting they may be less tightly associated with U33 under our experimental
conditions. An additional 39 proteins were also identified. Although 11 of these proteins
had been previously shown to interact with at least one snoRNA in prior
studies,93,94,113,114 28 proteins were novel snoRNP components. In order to validate the
mass spectrometry results, one of the most abundant proteins in the ASO pull-down,
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heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), was directly interrogated for
interaction with U33 by pull-down followed by western blot. Under the same conditions
for pull-downs from whole cell sonicate as described above, immunologically-detectable
hnRNP A1 co-precipitated with U33 ASO, while none was observed with the sense pulldown (Fig. 2.3B). Together, these results are consistent with our hypothesis that U33
interacts with non-canonical proteins.

Since the Rpl13a snoRNAs accumulate in the cytosol of multiple cell types during
lipotoxicity,42,97,102 we hypothesized that U33 might interact with a unique complement of
proteins in the cytosol following treatment of cells with pathophysiological
concentrations of palmitate, compared to nuclear U33 under homeostatic conditions. As
shown in Figure 2.4A, treatment of NIH-3T3 cells with 500 µM palmitate for 12 hours
results in a similar accumulation of the Rpl13a snoRNAs as has been previously shown
for CHO cells and C2C12 myoblasts. Based on this observation, we chose NIH-3T3
cells for the next series of experiments to compare the U33 snoRNP-proteome under
different conditions.

We next developed a method for recovering compartment-specific snoRNPs from the
cytosol (cyto) and the remainder of the cell (post-cytosolic, post-cyto). Buffers typically
used for extraction of cytosolic lysates contain 100 µg/mL digitonin, but these conditions
did not support enrichment of U33 by ASO pull-down (data not shown). In an alternate
approach, we homogenized cells in the 0.05% NP-40 buffer used above for isolating
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snoRNPs from whole cell sonicates, since this buffer permits binding of the ASO to U33,
yields U33 enrichment, and preserves interactions between the snoRNA and known
protein binding partners. Following Dounce homogenization, cytosol was separated
from membrane-bound organelles by centrifugation and the latter were then lysed by
sonication (post-cytosol). Western blot analysis showed the cytosolic fraction was
enriched for the cytosolic marker hsp90 and relatively depleted of nuclear markers
nucleophosmin and histone H3, whereas the post-cytosolic fraction was relatively
depleted for hsp90 and enriched for the nuclear markers (Fig. 2.4B). Further, RT-qPCR
for the predominantly nuclear RNA U6 indicated that this marker segregated between
the cytosolic and post-cytosolic fractions as expected. Neither the protein nor RNA
markers showed significant change with palmitate treatment. Therefore, lysates
generated by this approach were used to investigate the proteins bound to U33 in each
compartment.

Proteins isolated from oligo-mediated pull-downs performed with cytosolic and postcytosolic lysates, following treatment with palmitate or vehicle, were analyzed by mass
spectrometry. As a control, RNA isolated from these pull-downs was quantified by
RTqPCR (Fig. 2.4D). As we had observed with whole cell sonicates, in both the
cytosolic and post-cytosolic compartments under control and palmitate-treated
conditions, U33 was enriched by ASO pull-down when compared to sense pull-down,
while U20 and U17b were not. Pull-down was more efficient in the post-cytosolic
compartment, likely reflecting the higher absolute abundance of snoRNA in the nucleus
under both basal and stress conditions. Visualization of co-precipitating proteins by
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SDS-PAGE and SYPRO Ruby staining again revealed many ASO-specific bands (Fig.
2.4E). Additionally, the complement of proteins co-precipitating with cytosolic U33
appeared different than with post-cytosolic U33. Based on the results of these controls,
this approach specifically enriches for U33 snoRNPs and recovers substantially more
proteins than the four canonical snoRNP proteins in both fractions under the different
conditions.

Peptides from pull-downs performed in parallel to those shown in Figure 2.4E were
identified by mass spectrometry. Proteins with a minimum of five peptides and a 2:1
ratio of peptides in ASO versus sense pull-down from the same fraction/condition were
considered enriched. Given the accumulation of U33 and the other Rpl13a snoRNAs in
the cytosol during lipotoxicity, we hypothesized that proteins uniquely associated with
U33 in the cytosol following palmitate treatment, but not associated with U33 in the
post-cytosol under basal conditions, might be important to the function of U33 in the
cytosol during metabolic stress. 27 proteins were specifically associated with U33 in the
cytosol of palmitate-treated cells, but not with U33 in the post-cytosol of vehicle-treated
cells (Table 2.2 and Fig. 2.4F). On the other hand, proteins that only associated with
U33 in the post-cytosol under basal conditions might be involved in tethering the
snoRNA in the nucleus. 16 proteins were specifically associated with U33 in the nucleus
under basal conditions but not in the cytosol during lipotoxicity (Table 2.3). Lastly,
proteins that associated with U33 in both the cytosol during lipotoxicity and the postcytosol might be involved in trafficking of the snoRNA between the two compartments.
24 proteins were enriched for association with U33 in both the cytosol following
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palmitate treatment and in the post-cytosol following vehicle treatment (Table 2.4). The
mass spectrometry results indicated that U33 interacts with many proteins that had not
previously been described as snoRNP components, and that many of these interactions
are compartment- and treatment-specific.

Interactions between U33 and each of four proteins found to uniquely associate with the
snoRNA in the cytosol during lipotoxicity were first validated by pull-down/western blot.
Given that snoRNAs direct the modification of other RNAs, we hypothesized that U33
might act in the cytosol to direct mRNA modulating proteins to specific targets. We
therefore focused on proteins known to modulate the functions of mRNAs. Two proteins
with highly abundant peptides in the cytosolic pull-downs under lipotoxic conditions
were far upstream element binding protein 2 (KHSRP) and heteronuclear
ribonucleoprotein U (hnRNP U). These proteins play a role in regulation of mRNA
abundance through AU-rich elements (AREs).115,116 Pull-down of U33 from cytosolic
lysates of palmitate-treated cells not only enriched for U33 in ASO pull-downs, but also
for immunologically-detectable hnRNP U and KHSRP (Fig. 2.5A). We hypothesize that
the U33 snoRNP may direct these proteins to AU-rich element-containing transcripts in
order to regulate their abundance, a possibility that will be further addressed in Chapter
3. Another pair of proteins selected for validation, Ras GTPase-activating proteinbinding protein 1 (G3bp1) and Caprin-1, are known stress granule components that
could function in concert with U33 to directed specific transcripts to stress
granules.117,118 U33 pull-down from cytosolic lysates followed by western blotting
indicated co-precipitation of each protein with ASO, but not sense, pull-down (Fig.
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2.5B). While it is possible that U33 guides these proteins to sequester specific
transcripts for translational silencing, we did not observe induction of stress granule
formation under the lipotoxic conditions used for generation of cytosolic and postcytosolic lysates (data not shown).

In a complementary approach to validate snoRNA-protein interactions, identified
proteins were immunoprecipitated from cytosolic lysates of palmitate- and vehicletreated cells, with a parallel immunoprecipitation with normal IgG as a negative control.
Each of the four proteins above was precipitated by its antibody, but not by normal IgG
(Fig. 2.6). Co-precipitating U33 and tRNA-glutamate were quantified by RTqPCR and
DCT

enrichment was calculated as a single 2

. U33 was more than 2-fold enriched with

each protein in the cytoplasm, while another small RNA, tRNA-glutamate, was not.
Furthermore, association of U33 with cytosolic hnRNP U more than doubled during
lipotoxic stress (Fig. 2.6A), and the amount of immunologically detectable hnRNP U in
the cytosol increased considerably with palmitate treatment (Fig. 2.7). Similar
enrichment in the cytosolic fractions under lipotoxic conditions was not observed for the
other three proteins. Taken together, our validation experiments confirmed interactions
of U33 with hnRNP U, KHSRP, Caprin-1, and G3bp1 in the cytosol of palmitate-treated
cells.

21

2.3 Concluding Remarks and Future Directions
We have developed a method for isolation of U33 and its protein binding partners from
the subcellular compartments of palmitate-treated cells. Consistent with recent reports
for another box C/D snoRNA, MBII-52,93,94 U33 was found to associate with many more
proteins than the canonical four box C/D proteins, fibrillarin, Nop56, Nop58, and 15.5K.
A number of these U33-associated proteins have not been previously described as
snoRNP components.

To our knowledge, this is the first description of compartment- or treatment-specific
interactions between a snoRNA and its protein partners. While a number of U33associated proteins are present regardless of cell treatment or fraction, proteins that
associate only in the lipotoxic cytosol or the post-cytosolic compartment under
homeostatic conditions suggest that the snoRNPs are dynamic and undergo
remodeling. We hypothesize that proteins exclusively associated with U33 in the postcytosolic fraction under homeostatic conditions could play a role in canonical functions
of U33 in the nucleolus or tethering of the snoRNA in that compartment. Proteins that
are exclusively associated with U33 in the cytosol under lipotoxic conditions may
function in export of the snoRNA to the cyotosol or contribute to the function of the
snoRNA outside the nucleus.

We validated interactions of U33 with four specific proteins in the cytosol under lipotoxic
conditions. Interactions with the stress-granule associated proteins, Caprin-1 and
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G3bp1, and with the AU-rich element regulatory proteins KHSRP and hnRNP U,
suggest that U33 may modulate the functionality of mRNAs by directing one or more of
these proteins to mRNA targets in a sequence-specific manner. To date, there is no
data linking lipotoxic responses to regulation of transcript abundance through AREs. As
described in Chapter 3, AREs may be linked to the abundance of some genes
differentially expressed during lipotoxicity. Future studies will be required to test this
hypothesis. Proteins identified by mass spectrometry to bind U33 only in the basal postcytosol or in both the basal post-cytosol and lipotoxic cytosol will also be the subject of
future studies in the Schaffer lab.
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FIGURE 2.1
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Figure 2.1: RNAse H defines accessible regions of U33 in snoRNP
A. U33 sequence is shown with annotation of probes for RNase H analysis.
B. Following incubation of cell sonicates with indicated U33 probes, RNase H digestion was
performed to degrade RNA duplexes. Remaining U33 was quantified by RTqPCR relative to
Rplp0. N= 3 independent experiments, graph reports mean + standard error (SE). *p<0.01
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FIGURE 2.2
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Figure 2.2: Development of method to isolate U33 snoRNP
A. Scheme for isolation of endogenous U33 snoRNP using biotinylated antisense oligo. NIH3T3 cells were lysed by sonication in buffer containing 0.05% NP-40. Lysate was incubated for
1.5h with a biotinylated antisense oligo complementary to U33 nucleotides 53-72. OligosnoRNP complexes were captured with streptavidin-agarose, and RNA and protein were
isolated from beads. Parallel pull-down with biotinylated sense oligo was used as negative
control.
B. Recovered snoRNAs were quantified by RTqPCR. Graph reports ratios of snoRNAs
recovered with antisense (ASO) relative to sense oligos.
C. Co-precipitating fibrillarin and Nop58 were analyzed by western blot for sense (S) and
antisense (A) oligo pull-downs.
For all data, n = 3 independent experiments, graphs report means + standard error (SE), and
representative gels are shown. *, p < 0.05

25

FIGURE 2.3
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Figure 2.3: U33 binds many proteins in whole cell sonicate
Endogenous U33 snoRNP was isolated from whole cell sonicates of NIH-3T3 cells using
antisense oligo (A, ASO) and parallel reaction with sense oligo (S, sense) as negative control.
For each experiment, recovered RNA was analyzed by RTqPCR for snoRNAs. Graphs on left
report ratio of snoRNA recovered with ASO relative to sense control.
A. Proteins isolated from sense and antisense oligo pull-downs were separated by
polyacrylamide gel electrophoresis and visualized after SYPRO Ruby staining.
B. Proteins isolated from sense and antisense oligo pull-downs were analyzed by western
blotting for fibrillarin and hnRNP A1.
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Table 2.1: U33-associated proteins in whole cell sonicate
Table
2.1 U33-associated proteins in whole cell sonicate

NIH-3T3 cells were lysed by sonication in buffer containing 0.05% NP-40. U33 snoRNP was
isolated by antisense oligo mediated pull-down, with parallel sense oligo pull-down as control.
Co-precipitating proteins were identified by mass spectrometry. Proteins with ≥ 2 peptides (for
previously identified snoRNA binding proteins) or ≥ 5 peptides (for novel snoRNA binding
proteins) and at least 2-fold enrichment in A versus S pull-down were considered specific
snoRNP-associated proteins. *Previously identified snoRNA-interacting protein.

Description
Heterogeneous nuclear ribonucleoprotein M
*Heterogeneous nuclear ribonucleoprotein A1
Far upstream element-binding protein 2
*Heterogeneous nuclear ribonucleoproteins A2/B1
Heterogeneous nuclear ribonucleoprotein A/B
*Heterogeneous nuclear ribonucleoprotein A3
*Heterogeneous nuclear ribonucleoprotein D0
Myelin expression factor 2
Heterogeneous nuclear ribonucleoprotein A0
Polyadenylate-binding protein 1
*TAR DNA-binding protein 43
DAZ-associated protein 1
Uncharacterized protein Gm7964
Heterogeneous nuclear ribonucleoprotein Q
Heterogeneous nuclear ribonucleoprotein F
*Lupus La protein homolog
RNA binding protein fox-1 homolog 2
*ELAV-like protein 1
RNA binding motif protein, X-linked-like-1
Cellular nucleic acid-binding protein
Heterogeneous nuclear ribonucleoprotein R
*Heterogeneous nuclear ribonucleoprotein U-like protein 2
RNA-binding motif, single-stranded-interacting protein 1
Squamous cell carcinoma antigen recognized by T-cells 3
*Transcriptional activator protein Pur-alpha
Heterogeneous nuclear ribonucleoprotein H2
Poly(rC)-binding protein 2
G-rich sequence factor 1
Splicing factor U2AF 65 kDa subunit
Threonine--tRNA ligase, mitochondrial
*Transcriptional activator protein Pur-beta
*rRNA 2'-O-methyltransferase fibrillarin
Pre-mRNA-processing factor 19

Gene Symbol
Hnrnpm
Hnrnpa1
Khsrp
Hnrnpa2b1
Hnrnpab
Hnrnpa3
Hnrnpd
Myef2
Hnrnpa0
Pabpc1
Tardbp
Dazap1
Gm7964
Syncrip
Hnrnpf
Ssb
Rbfox2
Elavl1
Rbmxl1
Cnbp
Hnrnpr
Hnrnpul2
Rbms1
Sart3
Pura
Hnrnph2
Pcbp2
Grsf1
U2af2
Tars2
Purb
Fbl
Prpf19
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Number of
Peptides
(Whole cell;
experiment 1)
191
85
92
87
79
48
57
56
39
40
30
35
27
23
26
21
28
11
18
7
17
12
13
7
11
10
8
9
12
10
10
6
7

Number of
Peptides
(Whole cell;
experiment 2)
313
322
222
192
190
198
182
121
104
88
76
69
64
57
45
39
32
48
41
51
36
31
29
32
27
22
22
21
18
18
17
19
16

Protein Sf3b2
Transformer-2 protein homolog beta
THO complex subunit 4
RNA-binding protein 39
Zinc finger Ran-binding domain-containing protein 2
RNA-binding motif, single-stranded-interacting protein 2
*Nucleolar protein 58
*U3 small nucleolar ribonucleoprotein protein MPP10

Sf3b2
Tra2b
Alyref
Rbm39
Zranb2
Rbms2
NOP58
Mphosph10
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Figure 2.4: U33 binds different proteins depending on subcellular compartment and
lipotoxicity
NIH-3T3 cells were treated with 500 µM palmitate or vehicle (veh) for 12 hours.
A. Cytosol was recovered by differential degergent extraction using digitonin buffer. Cytosolic
RNA was analyzed for Rpl13a snoRNAs relative to Rplp0 by RTqPCR.
B-F. Cytoslic (cyto) and post-cytosolic lysates (post-cyto) were generated by Dounce
homogenization and sonication, respectively, in buffer containing 0.05% NP-40.
B. Protein markers for cytosol (hsp90) and nucleus (nucleophosmin [npm] and histone h3 [H3])
were analyzed by western blot.
C. Nuclear RNA marker U6 was quantified by RTqPCR in cyto and post-cyto lysates.
D. Endogenous U33 snoRNPs were isolated with antisense oligo (ASO) using parallel pull-down
with sense oligo as control. Graph reports quantification of snoRNAs in pull-down as recovery
with ASO relative to sense oligo.
E. Proteins co-precipitating with antisense (A) and sense (S) oligos were separated by
polyacrylamide gel electrophoresis and visualized with SYPRO Ruby.
F. Proteins in pull-downs were identified by mass spectrometry. Proteins with ³ 5 peptides and
at least 2-fold enrichment in A versus S pull-down were considered specific snoRNP-associated
proteins. Venn diagram reports the number of proteins associated with U33 only in the cytosol
during lipotoxicity (palm, cyto; n = 27), proteins associated with U33 only in the post-cytosol
fraction under homeostatic conditions (veh, post-cyto, n = 16), and proteins associated with U33
under both conditions (n = 24).
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Table 2.2: Proteins associated with U33 uniquely in cytosol during lipotoxicity
NIH-3T3 cells were treated with 500 µM palmitate or vehicle. Cytoslic (cyto) and post-cytosolic
lysates (post-cyto) were generated by Dounce homogenization (cyto) and sonication of
remaining organelles in buffer containing 0.05% NP-40 as in Figure 2.4. U33 snoRNP was
isolated by antisense oligo mediated pull-down, with parallel sense oligo pull-down as control.
Co-precipitating proteins were identified by mass spectrometry. Proteins with ³ 5 peptides and
at least 2-fold enrichment in A versus S pull-down were considered specific snoRNP-associated
proteins.
shows
proteins
that
with
U33 during
in the lipotoxicity
cytosol during lipotoxicity, but do
Table 2.2:Table
Proteins
associated
with
U33associate
uniquely in
cytosol
not associate with U33 in the post-cytosol under homeostatic condition.

Description

Peptide
Count
Gene
(Cyto;
Symbol palm) Function
RNA binding; mRNA metabolism; mRNA
regulation through AU-rich elements
RNA binding; transcription regulation
RNA binding
RNA binding; mRNA regulation through AUrich elements
transcription regulation,
regulation termination;
transcription
caveolae formation

Far upstream element-binding protein 2
Khsrp
Far upstream element-binding protein 3
Fubp3
RNA-binding motif, single-stranded-interacting protein 1 Rbms1

106
73
41

Heterogeneous nuclear ribonucleoprotein U
Transcriptional activator protein Pur-beta
Polymerase I and transcript release factor

Hnrnpu
Purb
Ptrf

34
18
17

Ras GTPase-activating protein-binding protein 1
Elongation factor 1-alpha 1

G3b1
Eef1a1

17
16

Caprin-1
Cellular nucleic acid-binding protein
Zinc finger Ran-binding domain-containing protein 2
RNA-binding motif, single-stranded-interacting protein 2
Replication protein A 70 kDa DNA-binding subunit

Caprin1
Cnbp
Zranb2
Rbms2
Rpa1

15
12
12
11
11

stress granule regulation; Wnt signaling
regulation
translation elongation
translation regulation; stress granule
component
transcription regulation
transcription regulation
Alternative splicing factor
DNA replication; DNA repair

Probable ATP-dependent RNA helicase DHX36
Ras GTPase-activating protein-binding protein 2

Dhx36
G3bp2

9
8

transcription regulation; mRNA stability
regulation through AU-rich elements
mRNA transport

High mobility group protein HMG-I/HMG-Y
Small nuclear ribonucleoprotein Sm D3
Protein PRRC2C
THO complex subunit 4

Hmga1
Snrpd3
Prrc2c
Alyref

8
7
7
6

transcription regulation; heterochromatic
organization
Core spliceosome component
RNA binding; hematopoietic differentiation
RNA export

Exosome complex exonuclease RRP44
Serine/threonine-protein kinase DCLK1
Heterogeneous nuclear ribonucleoprotein F
Small nuclear ribonucleoprotein Sm D1
tRNA-splicing ligase RtcB homolog
MAP7 domain-containing protein 1
RNA-binding protein NOB1
Serum deprivation-response protein

Dis3
Dclk1
Hnrnpf
Snrpd1
Rtcb
Map7d1
Nob1
Sdpr

6
6
5
5
5
5
5
5

Exonuclease; degradation of AU-rich element
containing mRNA
Microtubule regulation; neuronal migration
alternative splicing regulation
Core spliceosome component
tRNA splicing
microtubule assembly and stability
ribosome assembly
caveolae maintenance

30

Table 2.3: Proteins associated with U33 uniquely in post-cytosol fraction under
homeostatic conditions
NIH-3T3 cells were treated with 500 µM palmitate or vehicle. Cytoslic (cyto) and post-cytosolic
lysates (post-cyto) were generated by Dounce homogenization and sonication in buffer
containing 0.05% NP-40 as in Figure 2.4. U33 snoRNP was isolated by antisense oligo
mediated pull-down, with parallel sense oligo pull-down as control. Co-precipitating proteins
were identified by mass spectrometry. Proteins with ³ 5 peptides and at least 2-fold enrichment
in A versus S pull-down were considered specific snoRNP-associated proteins. Table shows
proteins that associate with U33 in the post-cytosol under homeostatic conditions, but do not
Table 2.3: Proteins associated with U33 uniquely in post-cytosol fraction under homeostatic conditions
associate
with U33 in the cytosol during lipotoxicity.

Description

Peptide
Gene Count (PostSymbol
cyto; veh) Function

RNA binding motif protein, X-linked-like-1

Rbmxl1

38

RNA splicing (possible)

Uncharacterized protein Gm7964

Gm7964

31

RNA binding

Heterogeneous nuclear ribonucleoprotein H2

Hnrnph2

21

Alternative splicing

Heterogeneous nuclear ribonucleoprotein Q

Syncrip

17

RNA stability; RNA editing

Elavl1

17

mRNA regulation through AU-rich elements

Sfpq

14

RNA splicing; transcriptional repression

Grsf1

14

mitocholdrial translation

Sf3bp2

12

RNA splicing

Heterogeneous nuclear ribonucleoprotein U-like protein 2 Hnrnpul2

12

DNA damage repair

RNA-binding protein FUS

ELAV-like protein 1
Splicing factor, proline- and glutamine-rich
G-rich sequence factor 1
Protein Sf3b2

Fus

8

RNA splicing

U2af2

8

RNA splicing; mRNA export

RNA-binding protein Raly

Raly

7

RNA binding

Keratin, type II cytoskeletal 7

Krt7

6

Cell structure

Snrpb2

6

RNA splicing

Sf1

5

RNA splicing; transcriptional repression

Srsf7

5

RNA splicing

Splicing factor U2AF 65 kDa subunit

U2 small nuclear ribonucleoprotein B''
Splicing factor 1
Serine/arginine-rich splicing factor 7
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Table 2.4: Proteins associated with U33 in both post-cytosol under homeostatic
conditions and cytosol during lipotoxicity
NIH-3T3 cells were treated with 500 µM palmitate or vehicle. Cytoslic (cyto) and post-cytosolic
lysates (post-cyto) were generated by Dounce homogenization and sonication in buffer
containing 0.05% NP-40 as in Figure 2.4. U33 snoRNP was isolated by antisense oligo
mediated pull-down, with parallel sense oligo pull-down as control. Co-precipitating proteins
were identified by mass spectrometry. Proteins with ³ 5 peptides and at least 2-fold enrichment
2.4: Proteins
associated
withconsidered
U33 in both post-cytosol
under homeostatic conditions
cytosol
during
inTable
A versus
S pull-down
were
specific snoRNP-associated
proteins.and
Table
shows
lipotoxicity
proteins that associate with U33 in both cytosol during lipotoxicity and post-cytosol under
homeostatic conditions.

Peptide
Peptide
Gene
Count (Cyto; Count (PostDescription
Symbol
palm)
cyto; veh)
Heterogeneous nuclear ribonucleoprotein M
Hnrnpm
286
162
Heterogeneous nuclear ribonucleoprotein A1
Hnrnpa1
102
377
Heterogeneous nuclear ribonucleoproteins A2/B1
Hnrnpa2b1
80
223
TAR DNA-binding protein 43
Tardbp
64
59
Heterogeneous nuclear ribonucleoprotein A3
Hnrnpa3
60
144
Uncharacterized protein Gm9242
Gm9242
56
140
DAZ associated protein 1, isoform CRA_b
Dazap1
35
32
Putative RNA-binding protein 3
Rbm3
28
27
Myelin expression factor 2
Myef2
27
92
Heterogeneous nuclear ribonucleoprotein A0
Hnrnpa0
37
55
Histone H2B type 1-F/J/L
Hist1h2bf
17
24
Heterogeneous nuclear ribonucleoprotein D0
Hnrnpd
135
176
Heterogeneous nuclear ribonucleoprotein D-like
Hnrnpdl
12
31
Squamous cell carcinoma antigen recognized by T-cells 3
Sart3
8
15
Heterogeneous nuclear ribonucleoprotein A/B
Hnrnpab
109
206
Heterogeneous nuclear ribonucleoprotein R
Hnrnpr
6
23
Lupus La protein homolog
Ssb
18
27
60S ribosomal protein L22
Rpl22
22
6
KH domain-containing, RNA-binding, signal transduction-associated protein 1 Khdrbs1
5
5
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Figure 2.5: Validation of U33 interactions with KHSRP, hnRNP U, Caprin-1, and G3bp1 by
ASO pull-down and western blotting
NIH-3T3 cells were treated with 500 µM palmitate or vehicle. Cytosolic lysates were collected by
Dounce homogenization as in Figure 2.4. U33 snoRNP was isolated by antisense oligo
mediated pull-down, with parallel sense oligo pull-down as control. Graphs on left of each panel
report recovered snoRNAs as quantified by RTqPCR for antisense oligo (ASO) pull-down
relative to sense oligo.
A. Recovered proteins were analyzed by western blot for hnRNP U and KHSRP.
B. Recovered proteins were analyzed by western blot for Caprin-1 and G3bp1.
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Figure 2.6: Validation of U33 interactions with KHSRP, hnRNP U, Caprin-1, and G3bp1 by
immunoprecipitation and qRT-PCR
NIH-3T3 cells were treated with 500 µM palmitate or vehicle. Cytosolic lysates were collected by
Dounce homogenization as in Figure 2.4. Immunoprecipitation was performed with antibody to
hnRNP U(A), KHSRP(B), Caprin-1(C), and G3bp1(D). Parallel immunoprecipitations with
normal rabbit IgG served as negative controls. In each panel, blot above graph shows western
analysis of immunoprecipitated proteins run alongside non-precipitated lysate. Graphs below
report RTqPCR quantification of co-precipitating U33 or glutamate tRNA (glu-tRNA) as a ratio of
RNA recovered with specific antibody relative to IgG.
34

FIGURE 2.7
cyto

-

+

post

-

+
100 kD

hnRNP U

50 kD

actin

Figure 2.7: hnRNP U accumulates in the cytoplasm during lipotoxic stress.
NIH-3T3 cells were treated with 500 µM palmitate or vehicle. Cytosolic and post-cytosolic
lysates were collected by Dounce homogenization and sonication, respectively, as in Figure 2.4.
Recovered proteins were analyzed by western blot for hnRNP U and actin.
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Chapter 3
Changes in Gene Expression During
Lipotoxicity
3.1 Introduction
Canonically, snoRNAs are found in the nucleolus, where they direct the chemical
modification of rRNA by complementary base pairing to the target. However, many
snoRNAs lack antisense complementarity to rRNA. Further, the snoRNAs MBII-52 and
HBII-52 have been shown to direct alternative splicing of the serotonin receptor 2C
through a mechanism that is proposed to involve direct modification of a non-canonical
target – the pre-mRNA.92 Accumulation of the Rpl13a snoRNAs in the cytosol during
lipotoxicity suggests that these snoRNAs may also target mRNAs, an abundant class of
RNAs in the cytoplasm.42,97 We hypothesized that modifications of mRNAs may result in
changes in the abundance or translation efficiency of some transcripts. In this chapter,
we report the results of RNA-seq and ribosome profiling experiments to identify
differential expression and translation of transcripts during lipotoxicity.

3.2 Results
In order to identify early changes in gene expression, RNA-seq was performed on NIH3T3 cells treated with palmitate or vehicle for 8 hours. At this time point, Rpl13a snoNAs
are readily detected in the cytosol (Fig. 3.1A), but cells remain tightly adherent to the
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culture dish, and there is no significant increase in cell death (data not shown). cDNA
libraries were prepared from duplicate total RNA samples, from which rRNA was
removed using RiboZero and sequencing was performed on an Illumina HiSeq 2500
platform. For the palmitate treated samples, the total number of reads was
approximately 49 million and 51 million, which yielded 43 million and 45 million mapped
reads. For the vehicle treated samples, the total number of reads was approximately 58
million and 44 million, which yielded 53 million and 38 million mapped reads. DESeq2
analysis indicated that transcripts for 194 genes were significantly upregulated by at
least 2-fold, with a false discovery rate (FDR) <0.05 (Table 3.1). Transcripts for 28
genes were significantly downregulated (FDR <0.05) and changed by at least 2-fold
(Table 3.1). Of these, representative up- and down-regulated transcripts were chosen
for RTqPCR validation in independent preparations of RNA from palmitate- and vehicletreated cells. All tested transcripts showed significant changes in abundance by
RTqPCR that correlated with the direction of change found by RNA-seq (Fig. 3.1B).
While the effect of palmitate treatment on gene expression has been extensively
reported for pancreatic beta cells119-121 and hepatic-derived cells,122,123 our data provide
new insights into changes in fibroblast gene expression during lipotoxicity.

We used DAVID 6.7 to perform gene ontology (GO) analysis of differentially expressed
transcripts following palmitate treatment.124,125 Among the differentially expressed
transcripts, the term “genes that regulate transcription” was significantly overrepresented (FDR < 0.05) (Table 3.2). 36 differentially expressed genes corresponded
to this biological process, including activating transcription factor 3 (Atf3), tribbles
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homolog 3 (Trib3), heme oxygenase 1 (Hmox1), and basonuclin 1 (Bnc1). Atf3, Trib3,
and Hmox1 were all upregulated during lipotoxicity in fibroblasts, similar to results seen
in pancreatic bcells following palmitate treatment.119 In addition to being previously
linked to lipotoxicity, all three genes have been implicated in translation or the
endoplasmic reticulum stress response.126-128 Bnc1 was downregulated by lipotoxic
stress. Bnc1 is a zinc finger protein that has been linked to maintenance of proliferative
capacity.129 Additionally, genes related to cell death and endoplasmic reticulum (ER)
stress were highly represented, but these terms did not reach statistical significance. 18
genes related to these biological processes included DNA-damage inducible transcript 3
(Ddit3), CCAAT/enhancer binding protein beta (Cebpb), and ERO1-like (Ero1l). Ddit3,
also known as Chop, is induced by ER stress and increases cellular ROS via the downregulation of Bcl-2.130 Cebpb mRNA levels are induced by ER stress, and the protein
interferes with the pro-survival functions of ATF4 during stress.131 Ero1l is a resident
ER protein that plays a role in oxidative protein folding.132 Previous studies of lipotoxicity
in other cell types found that genes related to transcription, ER stress, lipid metabolism,
and cell death were differentially expressed.119,122 Many of the differentially expressed
genes in our study, including thioredoxin interacting protein, myelocytomatosis
oncogene, Atf3, and growth arrest and DNA damage inducible 45a, were previously
linked to lipotoxicity.119 Still other genes, including Ski-like, Fam129a, and Snail
homolog 2, were previously linked to metabolism, stress, or cell death, but these results
are the first linking their expression to lipotoxicity.
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In view of our finding that U33 binds proteins known to regulate transcripts through
AREs (KHSRP and hnRNP U), we also examined whether regulated transcripts contain
AREs using AREsite 1.0 (http://rna.tbi.univie.ac.at/cgi-bin/AREsite.cgi).133 Remarkably,
while only 8-16% of the transcriptome contains AREs,133,134 33% of the transcripts
differentially expressed during lipotoxicity have AREs in their 3’-UTRs (Table 3.1).
Furthermore, Gene Set Enrichment Analysis135,136 indicated that genes containing
seven related ARE consensus sequences are upregulated in palmitate treated cells
(Table 3.3). These results suggest that palmitate treatment regulates abundance of
specific functional classes of transcripts and that regulation of gene expression could
relate to the presence of AREs in regulated transcripts.

AREs are known to mediate regulation of gene expression through changes in transcript
half-life.137,138 To test whether the regulation of transcript abundance was related to
changes in transcript half-life, we performed metabolic labeling. Cells were pulsed with
ethynyl uridine then chased with ethynyl uridine-free media under palmitate-treated or
control conditions. Following harvest of total cellular RNA, ethynyl uridine-containing
RNA was labeled with biotin, captured with streptavidin, and quantified by RTqPCR for
several regulated mRNAs. Stability of individual transcripts was estimated by comparing
the quantity of labeled RNA immediately after the pulse and following the chase for the
samples collected under lipotoxic and control conditions. RNA-seq showed transcripts
for Ppp1r15a, Ddit3, and Ptx3 were upregulated during lipotoxicity. Each of these
transcripts had increased stability during chase under lipotoxic conditions compared to
control (Fig. 3.2). RNA-seq showed that the transcript for Fasn was downregulated.
39

This transcript had decreased stability during lipotoxicity compared to control chase
conditions. The transcript for Rplp0, which was not differentially expressed during
lipotoxicity as quantified by RNA-seq, did not show any change in stability with palmitate
treatment. These results suggest that changes in RNA stability may play a role in the
abundance of transcripts that are differentially expressed during lipotoxicity.

The genetic screen in which the Rpl13a snoRNAs were identified also identified eEF1A1 as a critical gene in lipotoxicity.36 Given that eEF1A1 plays a role in peptide
elongation, we hypothesized that changes in translation efficiency could also contribute
to the biology of the lipotoxic response. In order to investigate this hypothesis, we used
a recently published ribosome profiling protocol.139 In parallel to the mRNA collected for
the RNA-seq described above under basal and lipotoxic conditions, we recovered
ribosome footprints, which are mRNA fragments protected from RNase digestion by the
presence of ribosomes, a feature of actively translated messages. The footprints were
used to construct cDNA libraries and sequenced on an Illumina HiSeq 2500 platform.
For the palmitate treated samples, the total number of reads was approximately 35
million and 27 million, which yielded 21 million and 13 million mapped reads. For the
vehicle treated samples, the total number of reads was approximately 33 million and 36
million, which yielded 21 million and 16 million mapped reads. DEseq2 analysis yielded
a list of 63 transcripts with significant differential footprint abundance under basal and
lipotoxic conditions (Table 3.4). To gauge translation efficiency, the relative read counts
for footprint abundance were normalized for relative read counts for transcript
abundance for each gene. We found 211 genes with a greater than 2-fold difference in
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the effect of palmitate on transcript abundance versus ribosome footprint abundance
(Fig. 3.3). This finding indicates that lipotoxicity regulates gene expression not just at
the level of transcription, but also at the level of translation.

Many previously published analyses of translation efficiency with ribosome footprinting
have relied on either a single sample set or biological duplicates, and the limited
statistical power given by these small sample sizes has limited analysis
approaches.140,141 Although we also sequenced and analyzed samples in duplicate, we
have developed a method to calculate statistical significance of changes in translational
efficiency. Following earlier approaches on analysis of RNA-Seq data,142 we pooled
read counts for genes in duplicated samples after normalizing to account for varying
sequencing depth, then constructed a fitted bivariate negative binomial distribution from
this count data under the assumption of equal translational efficiency in control vs.
treated cells. P-values were then calculated as the tail probability of this fitted
distribution given the count data and corrected for multiple hypothesis testing using the
Benjamini-Hochberg method to give a false discovery rate of 5%. To resolve the limited
statistical power of small sample sizes, we used a maximum a posteriori estimate for
gene-specific sample variance under each condition, using an exponential prior
distribution of the sample variance. Using this approach, we identified 65 genes whose
transcripts undergo significant differential translation efficiency with at least a 2-fold
change during lipotoxicity (Table 3.5). Ten of these transcripts are more efficiently
translated during lipotoxicity, while 55 are less efficiently translated.
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We identified gene ontology (GO) terms associated with each differentially translated
transcript with Panther 10.0.143-145 The terms cell communication, cell cycle, apoptotic
process, protein folding, and translation were each associated with several genes that
were differentially translated. The transcript with the largest increase in translational
efficiency was Rad21. Its protein product is cleaved by caspases 3 and 7 as an early
apoptotic event, and the resulting cleavage products are hypothesized contributors to
induction of apoptosis, possibly through dissociation from DNA.146 The P4hb transcript,
which encodes a protein disulfide isomerase (PDI), was translated much less efficiently
during lipotoxic stress. PDI is a pro-apoptotic protein shown to induce Bak
oligomerization.147 The Tp53 transcript, encoding the p53 protein, underwent one of the
most significant decreases (p<0.0001) in translation efficiency. The extensively studied
p53 protein is a key player in the apoptotic pathway in response to certain stimuli, and
its levels are tightly controlled.148 Decreased p53 results in a pro-survival phenotype;149
the decrease in p53 translation efficiency during early lipotoxic stress could be part of
an attempt at adaptation by the cell. These results further underscore the likelihood that
translational control plays a role in the cellular response to lipotoxic stress.

3.3 Concluding Remarks and Future Directions
RNA-seq of palmitate- and vehicle-treated NIH-3T3 fibroblasts has identified 222
differentially expressed genes. While many of the changes in expression matched
results seen in other cell types under lipotoxic conditions, we identified several novel
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lipotoxicity-regulated genes. Additionally, metabolic labeling has shown that changes in
mRNA stability contribute to the changes in transcript levels due to palmitate treatment.
One third of the genes that are differentially expressed during lipotoxicity contain AREs.
The role of these sequence elements in mediating changes in transcript levels during
lipotoxicity, and whether transcript stability is mediated by the ARE-binding proteins
found to bind U33, will be tested in future studies.

Ribosome profiling analysis indicated that gene expression during lipotoxicity is
regulated at the level of translation, with 65 transcripts undergoing significant changes
in translation efficiency following palmitate treatment. We have developed a novel
analysis pipeline to identify statistically significant changes in translation efficiency.
Additional studies will be needed to test this method in an independent sample set and
to validate that the observed changes in translational efficiency result in changes in
protein levels.
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Figure 3.1 Differential gene expression analysis of NIH-3T3 cells during lipotoxicity
A. NIH-3T3 cells were treated with 500 µM palmitate (palm) or vehicle (veh) for 8h. Cytosolic
RNA was collected following differential detergent extraction using digitonin buffer. Cytosolic
RNA was analyzed for Rpl13a snoRNAs relative to Rplp0 by RTqPCR. Graph represents mean
value from two independent experiments.
B. NIH-3T3 cells were treated with 500 µM palmitate or vehicle. RTqPCR validation of changes
in abundance, normalized to Rplp0, of select transcripts identified by RNA-seq. Graph
represents mean values + SE from 3 independent experiments. (Ppp1r15a: protein
phosphatase 1, regulatory subunit 15A; Gadd45a: growth arrest and DNA-damage-inducible,
alpha; Sqstm1: sequestosome 1; Fasn: fatty acid synthase)
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Table 3.1: Early changes in RNA abundance during lipotoxicity
NIH-3T3 cells were treated for 8h with 500 µM palmitate or vehicle. Table reports significantly
differentially expressed genes with > 2-fold change in RNA abundance. The presence of AUrich elements (AREs) in 3’-UTRs was queried for each gene using ARE-site 1.0.
Table 3.1 Early changes in RNA abundance during lipotoxicity

Gene Symbol
Atf3
Car6
Gadd45a
Ppp1r15a
Sh2d6
Fibin
Gm17173
Trib3
Slc7a11
Napb
Lif
Acot2
Gdap1l1
Rab39b
Angptl6
Chac1
Vldlr
Ddit3
Abca8b
Sh3bgrl2
Arid5a
Hmox1
P2rx7
Cth
Tnfsf18
Nfil3
Adamtsl3
Soat2
Casp4
Stard5
Slc6a9
Ptx3
2410006H16Rik
Stbd1
P2rx3
Mtm1
Plek
Gtpbp2
Rgs16

Gene Description
activating transcription factor 3
carbonic anhydrase 6
growth arrest and DNA-damage-inducible 45 alpha
protein phosphatase 1, regulatory (inhibitor) subunit 15A
SH2 domain containing 6
fin bud initiation factor homolog (zebrafish)
predicted gene 17173
tribbles homolog 3 (Drosophila)
solute carrier family 7 (cationic amino acid transporter, y+
system), member 11
N-ethylmaleimide sensitive fusion protein attachment protein
beta
leukemia inhibitory factor
acyl-CoA thioesterase 2
ganglioside-induced differentiation-associated protein 1-like 1
RAB39B, member RAS oncogene family
angiopoietin-like 6
ChaC, cation transport regulator 1
very low density lipoprotein receptor
DNA-damage inducible transcript 3
ATP-binding cassette, sub-family A (ABC1), member 8b
SH3 domain binding glutamic acid-rich protein like 2
AT rich interactive domain 5A (MRF1-like)
heme oxygenase (decycling) 1
purinergic receptor P2X, ligand-gated ion channel, 7
cystathionase (cystathionine gamma-lyase)
tumor necrosis factor (ligand) superfamily, member 18
nuclear factor, interleukin 3, regulated
ADAMTS-like 3
sterol O-acyltransferase 2
caspase 4, apoptosis-related cysteine peptidase
StAR-related lipid transfer (START) domain containing 5
solute carrier family 6 (neurotransmitter transporter, glycine),
member 9
pentraxin related gene
RIKEN cDNA 2410006H16 gene
starch binding domain 1
purinergic receptor P2X, ligand-gated ion channel, 3
X-linked myotubular myopathy gene 1
pleckstrin
GTP binding protein 2
regulator of G-protein signaling 16

45

P-value
Fold
Contains
(adjusted) Change
ARE
1.348E-99
22
1.9125E-37
12.3
1.0646E-92
9.8
3.374E-127
9.7
+
1.2912E-24
9.1
1.79E-13
9
+
4.1365E-10
8.6
4.4998E-78
7.2
3.8082E-46

6.8

1.0815E-45
3.9399E-37
9.5184E-59
1.7808E-08
3.5568E-18
1.3459E-14
9.0637E-57
3.7174E-35
1.1726E-49
3.7903E-07
1.634E-06
1.0342E-36
1.3252E-39
5.6509E-07
8.0714E-39
9.9276E-05
4.9827E-28
3.1895E-05
4.6613E-10
5.4869E-16
5.2669E-36

6.5
6.4
6.4
6.3
6
5.9
5.7
5.2
5.1
5
5
5
4.9
4.7
4.4
4.2
4.2
4.2
4
4
4

1.9837E-30
8.9421E-12
1.9002E-49
1.2405E-09
7.1151E-06
5.5181E-19
6.1197E-06
2.7583E-35
1.2564E-06

3.9
3.8
3.8
3.7
3.6
3.6
3.6
3.5
3.5

+

+
+

+

+
+
+

+

+
+
+
+

Ddit4
Pdk4
Slc3a2
Cdsn
Btg2
Ets2
Socs2
Klf11
Gch1
Dnmt3l
Sesn2
Txnip
Sqstm1
Herpud1
Fas
Cxcl1
Gpt2
Zfp945
Relb
Hectd2
Akna
Tlr2
Dlg2
Gm10557
Adh7
Trp53inp1
Prl2c1
Aldh1l2
Otub2
Ndrg1
Psph
Jhdm1d
Tulp2
Calcrl
Zfp184
Gm6806
Nupr1
Slc1a4
4922501C03Rik
Dhrs9
1500012F01Rik
Chka
Ero1l

DNA-damage-inducible transcript 4
pyruvate dehydrogenase kinase, isoenzyme 4
solute carrier family 3 (activators of dibasic and neutral amino
acid transport), member 2
corneodesmosin
B cell translocation gene 2, anti-proliferative
E26 avian leukemia oncogene 2, 3' domain
suppressor of cytokine signaling 2
Kruppel-like factor 11
GTP cyclohydrolase 1
DNA (cytosine-5-)-methyltransferase 3-like
sestrin 2
thioredoxin interacting protein
sequestosome 1
homocysteine-inducible, endoplasmic reticulum stressinducible, ubiquitin-like domain member 1
Fas (TNF receptor superfamily member 6)
chemokine (C-X-C motif) ligand 1
glutamic pyruvate transaminase (alanine aminotransferase) 2
zinc finger protein 945
avian reticuloendotheliosis viral (v-rel) oncogene related B
HECT domain containing 2
AT-hook transcription factor
toll-like receptor 2
discs, large homolog 2 (Drosophila)
predicted gene 10557
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
transformation related protein 53 inducible nuclear protein 1
Prolactin family 2, subfamily c, member 1
aldehyde dehydrogenase 1 family, member L2
OTU domain, ubiquitin aldehyde binding 2
N-myc downstream regulated gene 1
phosphoserine phosphatase
jumonji C domain-containing histone demethylase 1 homolog D
(S. cerevisiae)
tubby-like protein 2
calcitonin receptor-like
zinc finger protein 184 (Kruppel-like)
predicted gene 6806
nuclear protein transcription regulator 1
solute carrier family 1 (glutamate/neutral amino acid
transporter), member 4
RIKEN cDNA 4922501C03 gene
dehydrogenase/reductase (SDR family) member 9
RIKEN cDNA 1500012F01 gene
choline kinase alpha
ERO1-like (S. cerevisiae)
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2.2314E-17
1.1314E-30

3.5
3.5

5.9398E-43
0.00204192
2.1249E-15
1.1084E-27
8.8896E-14
2.0499E-15
0.00017766
8.1039E-05
3.2598E-26
7.0358E-16
4.0545E-41

3.4
3.4
3.3
3.3
3.2
3.2
3.2
3.1
3.1
3.1
3.1

2.7364E-34
8.3365E-05
6.9033E-06
4.1008E-29
7.4754E-17
7.3733E-20
2.4207E-09
1.1482E-16
1.662E-05
0.00038158
0.00018353
1.3352E-19
9.1844E-11
0.00260328
1.1705E-15
7.8783E-13
1.4104E-18
5.947E-27

3.1
3.1
3
3
3
3
2.9
2.9
2.9
2.9
2.9
2.9
2.8
2.8
2.8
2.8
2.8
2.8

1.5428E-14
0.00489871
3.0654E-10
5.123E-06
0.00035806
2.5799E-27

2.8
2.8
2.8
2.8
2.8
2.8

1.3383E-31
1.5331E-15
3.8071E-17
3.5614E-28
3.558E-22
2.935E-25

2.8
2.7
2.7
2.7
2.7
2.6

+

+
+
+
+

+

+
+

+
+
+
+

+

Il1rl2
Nnmt
Elavl2
Cd46
Cyb5r1
Ppef1
Gm15676
Arrdc4
Mmp28
Paqr3
Gm12258
Ddx26b
Pck2
Mib2
Clcn3
Gm15834
Apobr
Dennd4a
Them4
Grem1
Tmem154
Hhipl1
Pappa2
Fam110c
Rnd1
Stc2
Myc
Plk2
Gm129
Dus4l
Apobec1
Pde1a
Phf10
Dhrs7
Cebpβ
D8Ertd82e
Rora
Prl2c5
Lonp1
Aff1
Tspyl4
Cd209c
Zfp493
Psd3
1500002C15Rik

interleukin 1 receptor-like 2
nicotinamide N-methyltransferase
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu
antigen B)
CD46 antigen, complement regulatory protein
cytochrome b5 reductase 1
protein phosphatase with EF hand calcium-binding domain 1
predicted gene 15676
arrestin domain containing 4
matrix metallopeptidase 28 (epilysin)
progestin and adipoQ receptor family member III
predicted gene 12258
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
mindbomb homolog 2 (Drosophila)
chloride channel 3
predicted gene 15834
apolipoprotein B receptor
DENN/MADD domain containing 4A
thioesterase superfamily member 4
gremlin 1
transmembrane protein 154
hedgehog interacting protein-like 1
pappalysin 2
family with sequence similarity 110, member C
Rho family GTPase 1
stanniocalcin 2
myelocytomatosis oncogene
polo-like kinase 2
predicted gene 129
dihydrouridine synthase 4-like (S. cerevisiae)
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
phosphodiesterase 1A, calmodulin-dependent
PHD finger protein 10
dehydrogenase/reductase (SDR family) member 7
CCAAT/enhancer binding protein (C/EBP), beta
DNA segment, Chr 8, ERATO Doi 82, expressed
RAR-related orphan receptor alpha
prolactin family 2, subfamily c, member 5
lon peptidase 1, mitochondrial
AF4/FMR2 family, member 1
TSPY-like 4
CD209c antigen
zinc finger protein 493
pleckstrin and Sec7 domain containing 3
RIKEN cDNA 1500002C15 gene
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0.00057107
1.5607E-05

2.6
2.6

5.6665E-08
0.00190554
7.6321E-24
0.00122474
0.00023709
5.7316E-12
0.00687466
1.9219E-07
8.7082E-07
9.8859E-12
4.2982E-24
1.5097E-13
3.9567E-12
0.00026137
2.4654E-06
1.751E-12
7.5795E-07
7.2878E-13
6.0886E-05
2.2823E-07
0.00089663
2.7584E-15
5.9176E-15
2.2739E-14
2.4518E-19
3.7213E-20
0.00010292
7.0413E-09
8.5782E-06
0.00402413
1.3352E-19
1.1775E-08
8.8896E-14
6.3491E-13
1.4056E-05
0.00011491
5.0046E-21
1.1239E-17
2.6188E-09
5.8789E-08
0.0042491
6.602E-07
0.00019733

2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.3
2.3
2.3
2.3
2.3
2.3
2.3
2.3
2.3

+

+
+
+

+
+
+
+
+
+
+

+
+

Nfkbie
Zfp951
Rhbdd1
AC107744.1
Usp53
Manea
Nfxl1
Spry3
Fam53b
Rsbn1
Zc3h6
Vegfa
Dgat2
1810032O08Rik
Slc38a7
Nfkbia
Hmcn1
Gm21092
Chd2
Syne1
Taf15
Gm21811
Eda2r
CT030166.1
Cpox
Mitf
Slc7a5
Dnajb9
Mdfic
Lyst
Arhgef2
Junb
Stam
2810474O19Rik
Cnnm4
Npr3
Glce
A630007B06Rik
Garem
Cpt1a
Sash1
Zbtb10

nuclear factor of kappa light polypeptide gene enhancer in B
cells inhibitor, epsilon
zinc finger protein 951
rhomboid domain containing 1
None
ubiquitin specific peptidase 53
mannosidase, endo-alpha
nuclear transcription factor, X-box binding-like 1
sprouty homolog 3 (Drosophila)
family with sequence similarity 53, member B
rosbin, round spermatid basic protein 1
zinc finger CCCH type containing 6
vascular endothelial growth factor A
diacylglycerol O-acyltransferase 2
RIKEN cDNA 1810032O08 gene
solute carrier family 38, member 7
nuclear factor of kappa light polypeptide gene enhancer in B
cells inhibitor, alpha
hemicentin 1
predicted gene, 21092
chromodomain helicase DNA binding protein 2
spectrin repeat containing, nuclear envelope 1
TAF15 RNA polymerase II, TATA box binding protein (TBP)associated factor
predicted gene, 21811
ectodysplasin A2 receptor
None
coproporphyrinogen oxidase
microphthalmia-associated transcription factor
solute carrier family 7 (cationic amino acid transporter, y+
system), member 5
DnaJ (Hsp40) homolog, subfamily B, member 9
MyoD family inhibitor domain containing
lysosomal trafficking regulator
rho/rac guanine nucleotide exchange factor (GEF) 2
Jun-B oncogene
signal transducing adaptor molecule (SH3 domain and ITAM
motif) 1
RIKEN cDNA 2810474O19 gene
cyclin M4
natriuretic peptide receptor 3
glucuronyl C5-epimerase
RIKEN cDNA A630007B06 gene
GRB2 associated, regulator of MAPK1
carnitine palmitoyltransferase 1a, liver
SAM and SH3 domain containing 1
zinc finger and BTB domain containing 10
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4.0193E-05
0.00934122
5.7973E-13
1.0047E-13
1.7223E-11
1.6268E-08
3.5348E-08
2.6316E-06
0.0083614
1.5341E-12
8.9181E-05
2.2682E-15
0.00287386
1.0028E-08
1.8219E-13

2.3
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2

1.2104E-10
0.00412682
5.9799E-14
3.222E-12
1.2512E-06

2.2
2.2
2.2
2.1
2.1

1.5201E-06
3.9784E-05
9.8814E-09
1.1545E-05
2.6548E-11
0.00063436

2.1
2.1
2.1
2.1
2.1
2.1

2.152E-14
7.3011E-07
8.7612E-14
1.8589E-09
1.7299E-14
4.3091E-07

2.1
2.1
2.1
2.1
2.1
2.1

3.0818E-13
1.9017E-10
4.2178E-09
2.275E-07
6.2414E-15
1.1309E-10
2.7012E-07
1.1992E-12
7.5194E-12
3.605E-08

2.1
2.1
2.1
2.1
2.1
2.1
2.1
2.1
2.1
2.1

+
+
+
+
+
+

+
+
+
+
+
+
+

7.3481E-09
2.7207E-07
3.9716E-10
0.00562568
1.6687E-11
7.9161E-09

2
2
2
2
2
2

+
+
+
+
+
+

Sgtb
Fam171b
Pycr1
AC155814.1
Fam129a
3110043O21Rik
Clec2d
Fbxl12
Igfbp4
Tgif1
Skil
Snai2
Wisp1
Murc
Ugt1a6a
Fam135a
Zyg11b
Trim46
Deptor
Irs1
Cxcr7
Cyp1b1
Ccne1
Klhdc8a
Tmem50b
Tinagl1
Metrnl
Cd248
Gjb3
Ccsap
Oaf
Bnc1

kelch-like 24
tigger transposable element derived 2
proline-rich nuclear receptor coactivator 2
HtrA serine peptidase 1
growth arrest and DNA-damage-inducible 45 beta
serine/threonine kinase 40
small glutamine-rich tetratricopeptide repeat (TPR)-containing,
beta
family with sequence similarity 171, member B
pyrroline-5-carboxylate reductase 1
None
family with sequence similarity 129, member A
RIKEN cDNA 3110043O21 gene
C-type lectin domain family 2, member d
F-box and leucine-rich repeat protein 12
insulin-like growth factor binding protein 4
TGFB-induced factor homeobox 1
SKI-like
snail homolog 2 (Drosophila)
WNT1 inducible signaling pathway protein 1
muscle-related coiled-coil protein
UDP glucuronosyltransferase 1 family, polypeptide A6A
family with sequence similarity 135, member A
zyg-ll family member B, cell cycle regulator
tripartite motif-containing 46
DEP domain containing MTOR-interacting protein
insulin receptor substrate 1
chemokine (C-X-C motif) receptor 7
cytochrome P450, family 1, subfamily b, polypeptide 1
cyclin E1
kelch domain containing 8A
transmembrane protein 50B
tubulointerstitial nephritis antigen-like 1
meteorin, glial cell differentiation regulator-like
CD248 antigen, endosialin
gap junction protein, beta 3
centriole, cilia and spindle associated protein
OAF homolog (Drosophila)
basonuclin 1

3.1222E-06
9.4877E-06
2.9381E-07
0.0087947
0.00049161
2.1347E-08
1.2337E-10
3.7147E-05
6.1271E-06
2.6099E-12
2.7634E-13
5.7541E-05
3.2186E-12
0.00021647
0.00294592
6.3649E-09
4.8993E-14
6.7438E-05
0.0067323
3.6415E-12
6.8284E-09
6.6689E-05
2.4079E-07
1.776E-07
5.9096E-06
1.3831E-09
6.8517E-10
2.2833E-11
3.4221E-07
3.9472E-06
6.2856E-08
9.1486E-09

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
-2
-2
-2
-2
-2
-2
-2
-2
-2
-2
-2
-2
-2.1

+

Lfng
Fasn
AC158898.1
Acpl2
Spon2
Synpo

LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
fatty acid synthase
uncharacterized protein
acid phosphatase-like 2
spondin 2, extracellular matrix protein
synaptopodin

0.00037626
3.5029E-13
0.0055034
1.1768E-05
7.9585E-10
2.4285E-11

-2.1
-2.1
-2.1
-2.1
-2.2
-2.2

+

Klhl24
Tigd2
Pnrc2
Htra1
Gadd45b
Stk40
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+
+
+
+

+

+
+

Klk10
Apln
Cdc42ep2
Rnf145
Chst12
Ror1
4930483K19Rik
Plau
Mycn

kallikrein related-peptidase 10
apelin
CDC42 effector protein (Rho GTPase binding) 2
ring finger protein 145
carbohydrate sulfotransferase 12
receptor tyrosine kinase-like orphan receptor 1
RIKEN cDNA 4930483K19 gene
plasminogen activator, urokinase
v-myc myelocytomatosis viral related oncogene, neuroblastoma
derived (avian)
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0.00020662
2.1055E-09
2.5234E-13
7.8821E-16
0.00015234
0.00053053
0.00247085
2.87E-10

-2.2
-2.2
-2.3
-2.3
-2.3
-2.4
-2.7
-2.7

0.00119294

-2.8

+
+
+
+

Table 3.2: DAVID gene ontology analysis of genes differentially expressed during
lipotoxicity.
All genes with significant differential expression during lipotoxicity were analyzed by DAVID 6.7
with all detected genes as background. Table shows results for biological processes previously
implicated in lipotoxicity. Gene count is number of differentially expressed genes for each
process.
Table 3.2 DAVID Gene Ontology Analysis of Genes Differentially Expressed During Lipotoxicity
Biological Process
Regulation of Transcription
Regulation of Cell Death
Response to Protein Stimulus
Induction of Programmed Cell Death
Response to Endoplasmic Reticulum Stress

GO Identifier
GO:0045449
GO:0010941
GO:0051789
GO:0012502
GO:0034976
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Gene Count

FDR
36
15
6
8
4

0.0420
0.0804
0.0741
0.0763
0.1289

Table 3.3: Upregulation of ARE-containing transcripts by consensus sequence during
lipotoxicity
Gene set enrichment analysis (GSEA) was performed on RNA-seq data with genes containing
TableARE
3.3 Upregulation
of ARE-containing
consensus
sequence
lipotoxicity
each
consensus sequence
as customtranscripts
gene sets.by
Table
shows results
for during
analysis
with
10,000 gene-set permutations.
ARE Consensus Sequence
WWTATTTATWW
WWWATTTAWWW
WWWWATTTAWWWW
WWWTATTTATWWW
WTATTTATW
TTATTTATT
WWATTTAWW

FDR
<0.0007
<0.0007
<0.0007
0.000025
0.0001
0.0001
0.000486
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Ddit3
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-

Figure 3.2 Changes in transcript stability parallel changes in abundance
NIH-3T3 cells were pulsed with 0.3 µM ethynyl uridine for 2h, then chased in media without
ethynyl uridine while being treated with 500 µM palmitate or vehicle. Total RNA was collected,
ethynyl uridine-containing RNA was labeled with click-biotin, and labeled RNAs collected with
streptavidin:agarose beads. Labeled RNA was quantified by RTqPCR normalized to 18S rRNA,
and quantity recovered at the end of the chase is reported relative to quantity labeled by pulse.
Transcripts are grouped according to whether transcript abundance was found to be increased
or decreased by RNAseq analysis. (Ddit3: DNA-damage inducible transcript 3; Ptx3: pentraxin
related gene)
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Table 3.4 Early changes in ribosome footprint abundance during lipotoxicity

Table 3.4: Early changes in ribosome protected fragments during lipotoxicity
NIH-3T3 cells were treated for 8h with 500 µM palmitate or vehicle. Ribosomes were stalled on
transcripts with 100 µM cycloheximide. Ribosome protected fragments were generated by
digesting unprotected RNA with RNase I, collected by centrifugation, and analyzed by RNA-seq.
Table represents transcripts that were differentially abundant with >2-fold change among
ribosome protected fragments.

Gene Symbol
Ppp1r15a
Gadd45a
Hmox1
Ddit3
Acot2
Trib3

Description
Protein phosphatase 1, regulatory (inhibitor) subunit 15A
Growth arrest and DNA-damage-inducible 45 alpha
Heme oxygenase (decycling) 1
DNA-damage inducible transcript 3
Acyl-CoA thioesterase 2
Tribbles homolog 3 (Drosophila)

Solute carrier family 3 (activators of dibasic and neutral amino acid
transport), member 2
Cystathionase (cystathionine gamma-lyase)
ChaC, cation transport regulator 1
N-myc downstream regulated gene 1
Solute carrier family 6 (neurotransmitter transporter, glycine), member 9
Activating transcription factor 4
Small nucleolar RNA host gene 12
DNA-damage-inducible transcript 4
Regulator of G-protein signaling 16
Sequestosome 1
Phosphoserine phosphatase
Pentraxin related gene
Polo-like kinase 2
Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitinHerpud1
like domain member 1
Txnip
Thioredoxin interacting protein
2410006H16Rik RIKEN cDNA 2410006H16 gene
Ets2
E26 avian leukemia oncogene 2, 3' domain
Cyb5r1
Cytochrome b5 reductase 1
Lonp1
lon peptidase 1, mitochondrial
Nupr1
Nuclear protein transcription regulator 1
Pdk4
Pyruvate dehydrogenase kinase, isoenzyme 4
Emp2
Epithelial membrane protein 2
Fam110c
Family with sequence similarity 110, member C
Cpt1a
Carnitine palmitoyltransferase 1a, liver
Gpt2
Glutamic pyruvate transaminase (alanine aminotransferase) 2
Pck2
Phosphoenolpyruvate carboxykinase 2 (mitochondrial)
Steap1
Six transmembrane epithelial antigen of the prostate 1
Aldh1l2
Aldehyde dehydrogenase 1 family, member L2
Chka
Choline kinase alpha
Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor,
Nfkbia
alpha
Solute carrier family 7 (cationic amino acid transporter, y+ system), member
Slc7a5
5
Slc3a2
Cth
Chac1
Ndrg1
Slc6a9
Atf4
Snhg12
Ddit4
Rgs16
Sqstm1
Psph
Ptx3
Plk2
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P-value
Fold
(adjusted) Change
5.32E-22
10.6
6.88E-12
6.5
2.74E-20
5.4
8.21E-11
4.7
5.59E-07
4.3
4.71E-10
4.3
2.19E-18
3.09E-06
6.29E-07
1.77E-06
0.0000106
4.49E-11
0.0000587
0.0000736
3.73E-07
2.21E-14
4.53E-07
0.0005051
2.58E-08

3.9
3.7
3.7
3.5
3.4
3.4
3.3
3.3
3.2
3.2
3.1
3
2.8

0.0000732
0.0026899
0.0013976
0.0000841
4.43E-06
0.0000501
0.0005441
0.0032777
0.0006605
0.0095322
0.0050433
0.0060359
0.0004425
0.0021258
0.0004077
0.0060359

2.7
2.7
2.7
2.7
2.6
2.5
2.5
2.5
2.4
2.4
2.3
2.3
2.3
2.3
2.3
2.3

0.0196662

2.2

0.0005051

2.2

mt-Cytb
Myc
mt-Co3
Arid5b
mt-Nd4
Atf6
Zc3hav1
Ero1l
Aldh18a1
Yars
Arhgef2
mt-Nd5
Dpf2
Ptgs2
Sars
Slc1a4
mt-Atp6
Nop14
Tgif1
Ptprs
Col1a1
Rps19
Rpph1
Dhcr24
Emilin2
Fasn

Mitochondrially encoded cytochrome b
Myelocytomatosis oncogene
Mitochondrially encoded cytochrome c oxidase III
AT rich interactive domain 5B (MRF1-like)
Mitochondrially encoded NADH dehydrogenase 4
Activating transcription factor 6
Zinc finger CCCH type, antiviral 1
ERO1-like (S. cerevisiae)
Aldehyde dehydrogenase 18 family, member A1
Tyrosyl-tRNA synthetase
Rho/rac guanine nucleotide exchange factor (GEF) 2
Mitochondrially encoded NADH dehydrogenase 5
D4, zinc and double PHD fingers family 2
Prostaglandin-endoperoxide synthase 2
Seryl-aminoacyl-tRNA synthetase
Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4
Mitochondrially encoded ATP synthase 6
NOP14 nucleolar protein
TGFB-induced factor homeobox 1
Protein tyrosine phosphatase, receptor type, S
Collagen, type I, alpha 1
Ribosomal protein S19
Ribonuclease P RNA component H1
24-dehydrocholesterol reductase
Elastin microfibril interfacer 2
Fatty acid synthase

55

0.0002565
0.0001374
0.0004077
0.0357954
0.002218
0.0135638
0.002263
0.0144764
0.0022899
0.0014051
0.0062115
0.0062285
0.0197398
0.0005188
0.0002565
0.0175973
0.0010882
0.0147009
0.0062115
0.0265368
0.0001152
0.0003289
0.0033912
0.0002869
0.021616
5.84E-07

2.2
2.2
2.2
2.1
2.1
2.1
2.1
2.1
2
2
2
2
2
2
2
2
2
2
2
-2
-2
-2
-2
-2.1
-2.3
-2.5

log2 fold change, footprint abundance

Figure 3.3

log2 fold change, transcript abundance
Figure 3.3 Notable changes in translation efficiency
Fold change in transcript and footprint abundance were calculated using DESeq2 for each gene
upon palmitate treatment. Red dots represent genes for which there is more than a 2-fold
difference in change in footprint abundance versus change in transcript abundance upon
palmitate treatment, indicating possible translational regulation.
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Table 3.5 Significant Changes in Translation Efficiency

Table 3.5: Significant changes in translation efficiency
Translation efficiency was calculated for each gene as ratio of transcript abundance versus
footprint abundance. Translation efficiency ratio is translation efficiency for palmitate- versus
translation efficiency for vehicle-treated cells. Table shows genes for which translation efficiency
was significantly changed with palmitate treatment (p<0.05).
Translation
Efficiency Ratio
P-value
(Palm/Veh)
(adjusted)
45.0329
0.0146
43.2587
0.0013
33.0702
0.0017
30.9424
0.0024
16.2327
0.0004
11.8415
0.0112
9.1776
0.0002

Gene Symbol
Rad21
Rac1
Fdft1
Prmt1
Grn
Cd44
Col1a2

Description
RAD21 homolog (S. pombe)
RAS-related C3 botulinum substrate 1
farnesyl diphosphate farnesyl transferase 1
protein arginine N-methyltransferase 1
granulin
CD44 antigen
collagen, type I, alpha 2

Psmc2
Ncl

proteasome (prosome, macropain) 26S subunit,
ATPase 2
nucleolin

8.7409
4.7861

0.0146
0.0000

Slc25a4
Sgk1
Fkbp10
Atic
Tmbim6

solute carrier family 25 (mitochondrial carrier, adenine
nucleotide translocator), member 4
serum/glucocorticoid regulated kinase 1
FK506
binding protein 10
5-aminoimidazole-4-carboxamide
ribonucleotide
formyltransferase/IMP cyclohydrolase
transmembrane BAX inhibitor motif containing 6

2.9591
0.4959
0.4778
0.4740
0.4465

0.0287
0.0004
0.0004
0.0407
0.0093

Cct5
Gm15662
Cct7

chaperonin containing Tcp1, subunit 5 (epsilon)
predicted gene 15662
chaperonin containing Tcp1, subunit 7 (eta)

0.4093
0.4054
0.3952

0.0010
0.0241
0.0378

Psmb4
H2afx
Cox5a
mt-Tv
Tcp1

proteasome (prosome, macropain) subunit, beta type 4
H2A histone family, member X
cytochrome c oxidase subunit Va
mitochondrially encoded tRNA valine
t-complex protein 1

0.3909
0.3681
0.3659
0.3560
0.3431

0.0001
0.0428
0.0248
0.0065
0.0354

Fam198b
Fpgs
Dcaf7
Srsf1
Thoc5
Eef1g
Capns1
Hist1h2ah

family with sequence similarity 198, member B
folylpolyglutamyl synthetase
DDB1 and CUL4 associated factor 7
serine/arginine-rich splicing factor 1
THO complex 5
eukaryotic translation elongation factor 1 gamma
calpain, small subunit 1
histone cluster 1, H2ah

0.2933
0.2861
0.2827
0.2764
0.2519
0.2241
0.2172
0.2093

0.0156
0.0492
0.0287
0.0372
0.0114
0.0009
0.0000
0.0354

Kdelr2

KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum
protein retention receptor 2

0.1823

0.0018
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Sec24d
Sdpr
Tpr
Tnpo1
Tnc

Sec24 related gene family, member D (S. cerevisiae)
serum deprivation response
translocated promoter region
transportin 1
tenascin C

0.1810
0.1762
0.1756
0.1676
0.1624

0.0213
0.0159
0.0083
0.0087
0.0006

Psmd4
Fubp1
Ybx1
Tnks1bp1
Sep15
Cfl1
42069
Cav1
Eif3k

proteasome (prosome, macropain) 26S subunit, nonATPase, 4
far upstream element (FUSE) binding protein 1
Y box protein 1
tankyrase 1 binding protein 1
selenoprotein
cofilin 1, non-muscle
membrane-associated ring finger (C3HC4) 6
caveolin 1, caveolae protein
eukaryotic translation initiation factor 3, subunit K

0.1491
0.1390
0.1374
0.1317
0.1196
0.1195
0.1035
0.0906
0.0862

0.0293
0.0240
0.0152
0.0000
0.0065
0.0101
0.0354
0.0007
0.0001

0.0824
0.0747
0.0744

0.0159
0.0061
<0.0001

0.0678
0.0590

0.0373
<0.0001

0.0565
0.0529
0.0486
0.0478
0.0465

0.0009
0.0006
0.0170
0.0357
0.0040

Ddost
Itgav
Coa3
Arpp19
Nap1l4

ATPase, H+ transporting, lysosomal accessory protein
1
cytochrome c oxidase subunit Vic
actinin, alpha 1
solute carrier family 4 (anion exchanger), member 1,
adaptor protein
transformation related protein 53
dolichyl-di-phosphooligosaccharide-protein
glycotransferase
integrin alpha V
cytochrome C oxidase assembly factor 3
cAMP-regulated phosphoprotein 19
nucleosome assembly protein 1-like 4

Txndc12
Rplp2
Tars
Ddx23
Rps13
Hist1h2bk

thioredoxin domain containing 12 (endoplasmic
reticulum)
ribosomal protein, large P2
threonyl-tRNA synthetase
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23
ribosomal protein S13
histone cluster 1, H2bk

0.0450
0.0442
0.0430
0.0360
0.0352
0.0311

0.0354
0.0002
0.0000
0.0007
0.0492
0.0357

Cap1

CAP, adenylate cyclase-associated protein 1 (yeast)

0.0275

<0.0001

Gnai3
Emd
P4hb

guanine nucleotide binding protein (G protein), alpha
inhibiting 3
emerin
prolyl 4-hydroxylase, beta polypeptide

0.0196
0.0103
0.0061

0.0140
0.0027
0.0001

Atp6ap1
Cox6c
Actn1
Slc4a1ap
Trp53
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Chapter 4
Discussion
In this study, we tested the hypothesis that the C/D box snoRNA U33, which accumulates in the
cytosol during lipotoxicity and is required with the other Rpl13a snoRNAs for the lipotoxic
response, forms non-canonical snoRNPs. We showed that in whole cell lysates U33 interacts
with 28 proteins not previously described as snoRNP components. Additionally, we developed a
method for the isolation of U33 complexes from subcellular fractions and identified a number of
proteins whose interactions with U33 are dependent on fraction and treatment condition. We
validated several of these interactions, including hnRNP A1 in whole cells and hnRNP U,
KHSRP, G3bp1, and Caprin-1 in the cytosol of palmitate-treated cells. We hypothesized that
U33 might direct the proteins in its cytosolic snoRNPs to act on cytosolic RNAs, particularly
mRNAs, to change mRNA abundance, half-life, or translation efficiency. Therefore, we
performed RNA-seq and ribosome profiling on palmitate- and vehicle-treated cells. We found
changes in transcript abundance and translation efficiency, as well as transcript stability, during
lipotoxicity. Our findings that U33 forms non-canonical snoRNPs during lipotoxic stress and that
gene expression during lipotoxicity is regulated at several levels are consistent with U33
functioning in a non-canonical role in lipotoxicity.

Although snoRNAs were initially thought to exclusively direct the canonical core snoRNP
subunits to modify rRNA, more recent work has provided evidence for additional functions of
snoRNAs. The first identified non-canonical role was for a subset of snoRNAs now termed
scaRNAs. These small RNAs bind to canonical snoRNP subunits, but reside in Cajal bodies and
direct modification of snRNAs.89,91 Other snoRNAs have been shown to form non-canonical
snoRNPs that may relate to their unique functions. The brain-specific snordII-52 family of
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snoRNAs interacts with a number of non-canonical proteins, including ELAVL1 and nucleolin, to
direct the alternative splicing of the serotonin receptor 2C transcript.93,94 Human snoRNA ACA45
and Giardia lamblia snoRNA GlsR17 are both processed to smaller microRNA species that
function with Argonaute and modulate translation of Cdc2l6 and reporter constructs,
respectively.95,96

Our mass spectrometry results indicate that U33 interacts with a number of non-canonical
snoRNP components, many of which were not previously identified as snoRNA binding proteins.
Many of these interactions are dynamic, changing due to palmitate treatment or subcellular
localization of U33. We hypothesized that U33 directs cytoplasmic complexes to modify
cytoplasmic RNAs during lipotoxic stress. Therefore we focused our validation experiments on
four proteins known to interact with mRNAs and found to associate with U33 in the cytoplasm
after palmitate treatment, but not in the nucleus under basal conditions.

hnRNP U is a multifunctional protein with RNA and DNA binding capabilities. Loss of hnRNP U
leads to aberrant alternative splicing events and lethal defects in cardiac development.150 We
selected this protein for validation because, in addition to its general RNA-binding capabilities, it
has been shown to translocate to the cytoplasm of macrophages following lipopolysaccharide
(LPS) treatment and to stabilize cytokine mRNAs.116 We found that hnRNP U was significantly
increased in the cytosol of palmitate treated NIH-3T3 cells. Additionally, association of hnRNP U
and U33 increased under these conditions. The transcripts stabilized by hnRNP U in LPStreated macrophages contain AU-rich elements (AREs) in their 3’-UTRs.116 hnRNP U interacts
with these RNAs by binding to the AREs through its RGG motif; however, the mechanism of
target identification is unknown and only a small subset of expressed ARE-containing mRNAs
were affected by hnRNP U in this study.116 Intriguingly, our RNA-seq results indicate that during
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lipotoxcity a significant number of differentially abundant transcripts also contain AREs.
Metabolic labeling demonstrated changes in half-life that paralleled the changes in abundance
measured by RNA-seq for all transcripts tested. Together, these results suggest a model
whereby lipotoxicity induces interactions between U33 and hnRNP U in the cytoplasm, with U33
directing those complexes to ARE-containing mRNAs, resulting in altered stability.

Future studies will be required to determine whether U33 plays a role in stability of specific
transcripts and whether there is a physical interaction involving U33, the mRNA, and hnRNP U.
While such a mechanism might explain differential abundance for ARE-containing transcripts,
there were also differentially expressed transcripts that did not contain identifiable AREs. It is
possible that ARE-containing transcripts undergo changes in stability via one mechanism, while
non-ARE-containing transcripts are regulated by a distinct mechanism. Furthermore, while most
differentially abundant transcripts were increased by lipotoxicity, some were decreased; both
groups included ARE-containing mRNAs. hnRNP U has primarily been associated with
increasing ARE-containing transcript stability, leading to increased abundance of those
transcripts.116 The decreases in transcript stability seen in our RNA-seq study may be due to
factors besides hnRNP U, such as KHSRP. Alternatively, hnRNP U may mediate both up- and
down-regulation of transcript stability, depending on cis-acting elements within the modulated
RNA or the association of other proteins with the complex.

KHSRP is another ARE-binding protein that regulates the stability of certain transcripts and that
we have shown interacts with U33 in the cytoplasm of palmitate-treated cells. This protein binds
AREs and recruits proteins involved in mRNA decay, leading to decreased stability.151 KHSRP
tethers Parn, Ccr4, Dcp2, Xrn1, and Mtr3, as well as the exosome components Rrp4, Rrp46,
and PM-Schl100, to its target transcripts.115 Although KHSRP appears capable of regulating
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transcripts with different classes of ARE consensus sequences, it does not regulate all AREcontaining transcripts.115 Additionally, KHSRP regulation appears to be cell-type specific.
Further, the presence of additional cis-acting sequence elements within the mRNA can
modulate the effect of KHSRP binding.115 The G-CSF mRNA contains what has been termed
the stem-loop destabilizing element (SLDE) in its 3’-UTR and that is distinct from the ARE motif,
while the c-fos transcript has a destabilizing sequence motif within the coding region.137,152 The
stability of several other ARE-containing transcripts has been shown to be modulated by
additional sequence elements in the 3’-UTR; while some of these also form stem-loops, these
elements do not seem to form a single functional class.137,153 Furthermore, the molecular
mechanisms by which these elements modulate mRNA stability are not well-understood, and it
is possible that additional elements exist in other transcripts.

Our mass spectrometry results indicate that KHSRP interacts with U33 in the cytosol during
lipotoxic stress, but not in the nucleus under basal conditions. This suggests that KHSRP might
contribute to the non-canonical role of U33 in lipotoxicity. However, pull-down/western blot and
IP-qPCR validation experiments indicate that the interaction occurs in the cytosol with and
without stress. One possibility is that U33 is always found in a complex with KHSRP in the
cytosol, and that a modification to the complex or target(s) changes the ability of the complex to
act on the target(s). That modification might be the addition or departure of another protein
subunit to the complex, or a chemical modification such as phosphylation. Alternatively, KHSRP
might not contribute directly to the role of U33 in lipotoxicity. Instead, KHSRP might tether U33
in the cytosol.

We also validated interactions between U33 and two stress granule (SG) components, G3bp1
and Caprin-1. Stress granules are non-membrane bound cytoplasmic inclusions that are not
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present under basal conditions, but that form in response to a variety of stresses.154 SGs have
been observed in a variety of cell types in response to elevated temperature, oxidative stress,
and exposure to UV light.155 The prevailing view is that these granules are storage sites for
mRNAs in abortive translation complexes, which aggregate during periods of massive
translational arrest.154,156-158 Some studies have implicated SGs as sites of mRNA degradation,
although most mRNA turnover is thought to occur in P-bodies.157 SG nucleation is commonly
precipitated by eukaryotic initiation factor (eIF) 2 phosphorylation, which inhibits translation
initiation.154,159 Although there is debate in the literature, many studies indicate that mRNAs are
triaged in SGs, with some transcripts being sorted to P-bodies for degradation, some being held
in SGs for storage, and some transcripts with functions in the stress response being returned to
the cytosol for resumption of translation.160 These studies are complicated by the dynamic
nature of SGs, as well the overlap in protein constituents with P-bodies. Although the full
complement of SG proteins is unclear and varies by stressor, G3bp1 has been shown to be a
regulator of SG induction.161

G3bp1 is an RNA binding protein with evidence of endonuclease activity.162 While it is required
for SG formation in some experimental systems, other studies have indicated that SGs can form
without this protein, albeit with smaller size and fewer interactions with P-bodies.161,163 G3bp1
interacts directly with Caprin-1. Caprin-1 is required for normal progression through the G1-S
phase of the cell cycle and also co-localizes with G3bp1 in stress granules.118,164 Through its
carboxy-terminal region, Caprin-1 has been shown to bind select mRNAs, including c-myc and
cyclin D2.118 Although its overexpression can drive eIF2 phosphorylation and global translation
inhibition, Caprin-1 is not required for SG formation.118 While G3bp1 seems to play a role in
regulating SG size and interactions with other RNA granules, the role of Caprin-1 in SG function
remains undefined.
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G3bp1 and Caprin-1 were found to associate with U33 in the cytosol of palmitate treated cells,
but not in the nucleus of vehicle-treated cells. We chose to validate these interactions because
we hypothesized that Rpl13a snoRNA accumulation in the cytosol results in changes in
transcript abundance or translation efficiency that mediate lipotoxic cell death. One possible
mechanism could involve sequestration of those transcripts in SGs, with U33 mediating
selection of some mRNA targets. Validation experiments did show that U33 interacts with both
proteins in the cytosol. However, palmitate treatment did not induce the appearance of SGs in
NIH-3T3 cells. Treatment with the classical SG-inducer arsenite, which causes oxidative stress,
resulted in robust aggregation of both Caprin-1 and G3bp1 in the cytoplasm of NIH-3T3 cells,
indicating that these cells were competent for SG formation. One possible explanation is that
these proteins do interact with transcripts that undergo translational arrest following palmitate
treatment, but that lipotoxicity does not result in sufficiently “massive” translational arrest to
induce SG aggregates that are visible by fluorescent microscopy. Both G3bp1 and Caprin-1
have additional functions unrelated to SG formation. G3bp1 has been shown to cleave the ARE
of c-myc in vitro. U33 could direct G3bp1 to degrade some mRNAs that are destabilized and
less abundant during lipotoxicity, as shown in our RNA-seq study. Alternatively, U33 could direct
G3bp1 and Caprin-1 to perform some yet to be described function(s) on the RNAs that are
differentially abundant or differentially translated during lipotoxic stress. Similarly to results for
KHSRP, U33 was found to interact with G3bp1 and Caprin-1 in the cytosol in both palmitateand vehicle-treated cells. Again, this could indicate that additional factors mediate a switch from
inactive to active complexes during lipotoxicity.

For proteins shown to interact with U33 in the cytoplasm during lipotoxicity, future loss of
function or knockdown studies would be useful to establish a role for each protein in lipotoxicity.
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Loss of any one of these proteins might change the accumulation of U33 in the cytoplasm. This
possibility is particularly intriguing for hnRNP U, whose accumulation in the cytosol mirrors that
of U33; it is possible that the two traffic together. Alternatively, loss of one of these proteins
might attenuate some or all of the changes in mRNA abundance, stability, or translation
efficiency seen during lipotoxic stress. hnRNP U and KHSRP, given their published roles, are
more likely to be linked to transcript stability and abundance. Due to the role of stress granules
in both storing transcripts during translational arrest and sorting some of those transcripts to Pbodies for degradation, G3bp1 and Caprin-1 could be involved in changing mRNA abundance,
stability, and/or translation efficiency.

While disruption of the Rpl13a locus, with subsequent loss of all four encoded snoRNAs, is
protective against lipotoxicity, knockdown of individual snoRNAs by antisense oligo-mediated
knockdown has no effect.42 This suggests that the functions of the snoRNAs in the lipotoxic
response are either redundant or cooperative. Isolation of RNPs containing the remaining
Rpl13a snoRNAs by antisense oligo-mediated pull-down, followed by mass spectrometry, will
provide additional insights. The four snoRNAs might bind some of the same proteins,
suggesting that they direct similar modifications. Alternatively, the snoRNAs might bind different
proteins with related functions to facilitate cooperative action on a set of targets. Identification of
the full set of proteins interacting with the Rpl13a snoRNAs will provide greater insight into their
mechanism of action during lipotoxicity.

We hypothesize that the Rpl13a snoRNAs direct chemical modifications of mRNA
that alter stability and or translation efficiency. This could lead to changes in transcript
abundance due to altered stability or changes in ribosome profiles due to altered translation
efficiency. Indeed, RNA-seq identified over 200 transcripts with significant changes in
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abundance. Additionally, 65 transcripts underwent significant and discordant changes in
transcript abundance and ribosome protected footprint abundance during lipotoxicity, indicating
a change in translation efficiency. In addition, metabolic labeling studies indicated that changes
in transcript stability may have contributed to changes in transcript abundance.

Intriguingly, the majority of differentially abundant transcripts during lipotoxic stress in fibroblasts
showed an increase in abundance. As prolonged lipotoxic stress results in apoptosis, we
expected most transcripts to decrease in abundance. A recent RNA-seq study of human islet
preparations found that twice as many genes were downregulated as upregulated by palmitate
treatment.119 That study was performed at 48 hours of treatment, a time point that resulted in a
significant increase in propidium iodide (PI) positivity in treated cells. We chose a shorter time
point during lipotoxic stress that preceded PI positivity, but was sufficient to observe cytoplasmic
accumulation of the Rpl13a snoRNAs, because our goal was to investigate early effects of
cytosolic snoRNA accumulation. The increased abundance of many transcripts might reflect
activation of survival pathways during early lipotoxic stress. Significant enrichment of
transcription factors among differentially expressed genes could function to regulate such
adaptive pathways, a possibility that could be elucidated by additional experiments at later time
points. Given that prolonged exposure to lipotoxic stress is lethal, we would expect that RNAseq performed at substantially later time points (e.g., 36-48 hours) would reveal a larger
absolute number and relative amount of down regulated transcripts.

Ribosome profiling, in combination with the RNA-seq study, identified 65 transcripts with
significantly altered translation efficiency during lipotoxic stress. We developed a novel method
to resolve the typically limited statistical power of small sample sizes, using a maximum a
posteriori estimate for gene-specific sample variance and an exponential prior distribution of the
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sample variance. These results indicate that gene expression during lipotoxicity is controlled not
only at the level of transcription or mRNA abundance, but also at the level of translation. To our
knowledge, this is the first study to define changes in the “translatome” of palmitate-treated
cells. Additional experiments using snoRNA and/or snoRNP protein loss-of-function will be
necessary to determine the contribution of Rpl13a snoRNAs and their associated proteins to
changes in translation efficiency. In response to the oxidative stress induced by doxorubicin
treatment, others in the Schaffer lab have observed that box C/D snoRNAs as a class
accumulate in the cytosol with palmitate treatment.102 It is possible that changes in translation
efficiency not due to Rpl13a snoRNAs are driven by other snoRNAs. Alternatively, changes in
translation efficiency may occur via snoRNA-independent mechanisms. Although stress
granules were not detected by immunofluorescence during lipotoxicity, some translation
changes could be mediated by proteins that associate with stress granules. RNA-seq of
transcripts co-precipitating with Caprin-1, G3bp1, or other stress granule components under
basal and lipotoxic conditions could reveal whether these proteins bind transcripts shown to be
translationally regulated.

Identification of the cytoplasmic targets of the Rpl13a snoRNAs will provide insights into the
function of the snoRNAs in lipotoxicity and add to our understanding of cellular functions carried
out by these non-coding RNAs. The canonical snoRNA-target interaction occurs via duplex
formation at an antisense element (ASE) immediately upstream of the D box.84 The antisense
oligo (ASO) used to isolate U33 snoRNPs binds at this region. It is unknown whether U33 uses
the canonical ASE for interactions in the cytosol, which would preclude isolation of U33-target
complexes with this oligo. However, our RNase H assay identified a second region of U33,
closer to the 5’ end, that is also available for binding under lysis conditions that preserve U33protein interactions. Isolation of U33 complexes with biotinylated oligos that bind either the ASE
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or the upstream accessible region, followed by sequencing of co-precipitating RNAs might allow
identification of U33 targets, as has recently been done for the H/ACA box snoRNA
Snora73a.165 Additionally, comparison of the results with our RNA-seq and ribosome profiling
results may provide insights into the effect of these interactions. We expect that this approach
can be used to identify the targets of the Rpl13a snoRNAs, thereby providing additional insight
into the mechanism of action of these noncoding RNAs in the cellular response to lipotoxic
stress.
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Chapter 5
Materials and Methods
Cell Culture
NIH-3T3 cells (American Type Culture Collection) were cultured in Dulbecco’s Modified Eagle’s
Medium containing 10% calf serum, 50 units/mL penicillin and streptomycin, and 2 mM Lglutamine. For lipotoxicity experiments, 20 mM palmitate (Nu-Chek Prep) was freshly
complexed to bovine serum albumin (BSA, Lampire) at 2:1 molar ratio as previously
described,35 and added to cell culture media to achieve final palmitate concentration of 500 µM.
Equivalent amount of BSA (vehicle) was added to control samples. Incubations in palmitate or
vehicle supplemented media ranged from 8-12 h.

RNase H Assay
Protocol was based on previously published approach111 and modified as follows. Whole cell
lysates were generated by sonication in TNEN (50 mM Tris pH 8, 150 mM NaCl, 0.1. mM
EDTA, 0.05% NP-40) for 10 pulses of 10 seconds each, separated by 1 minute on ice.
Sonication was performed with Branson Sonifier 250 with microtip attachment at setting 4, 80%
duty cycle, corresponding to ~25 watts. Sonicate was subsequently centrifuged at 7,000xg at
4oC to pellet unbroken cells and nuclei. Supernatant was collected for RNAse H analysis.
Reactions contained equal volumes sonicate and 2X buffer (100 mM KCl, 10 mM MgCl2, 2 mM
DTT, 10% glycerol), 0.5 µL RNase H (Life Technologies), and 1 µL DNA oligo or water.
Reactions were incubated in a thermal cycler at 37oC for 15 minutes, then 30oC for 20 minutes.
Reactions were stopped with 9X volume of stop solution (0.1% SDS, 5 mM EDTA). RNA was
isolated by phenol:chloroform extraction and quantified by RTqPCR.
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RNA Reverse Transcription and Quantitative PCR
RNA isolated by phenol:chloroform extraction or with TRIzol or TRIzol LS (Life Technologies)
per manufacturer’s instructions was reverse transcribed using Superscript III First Strand
Synthesis System (Life Technologies) per manufacturer’s protocol. cDNA synthesis was primed
using random hexamers or oligo dT for rRNA and mRNA targets, or stem-loop or gene-specific
primers for snoRNAs, tRNAs, and 7SK. cDNA was amplified through 40 PCR cycles with Power
SYBR Green PCR Master Mix (Applied Biosystems) and 100 nM each forward and reverse
primers. Relative quantification of gene expression was performed using the comparative
threshold method. Relative quantification of RNA co-precipitating with antisense oligo or protein
immunoprecipitation was performed as 2

DCT

.

SnoRNP Isolation
Whole cell lysates were generated by sonication in TNEN for 5 pulses of 5 seconds each,
separated by 1 minute on ice. Sonication was performed with Branson Sonifier 250 with microtip
attachment at setting 4, 80% duty cycle, corresponding to ~25 watts. Sonicate was centrifuged
at 7,000xg at 4oC and supernatant was collected. For isolation of cytosol and post-cytosol, cells
were disrupted in TNEN by 10 strokes with Dounce homogenizer, then centrifuged at 20,000xg
for 30 minutes at 4oC. U6 RNA and protein markers (hsp90, histone H3, and nucleophosmin)
were used to validate subcellular fractionation by RTqPCR and western blot, respectively.
Supernatant was collected for cytosolic snoRNP isolation. Pellet was rinsed three times with
cold PBS then sonicated in TNEN as above. 250 µL lysate was incubated with 1 nanomole dualbiotinylated oligo (IDT) for 1.5 hours at 4oC with end-over-end rotation. 30 µL packed bead
volume of High-Capacity Streptavidin beads (Pierce) were incubated with lysate for 30 minutes
at 28oC. Beads were washed twice with 500 µL and three times with 1 mL TNEN. 90% of beads
were pelleted and protein collected by boiling in Laemmli sample buffer. RNA was isolated from
remaining 10% of beads with TRIzol-LS.
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Mass Spectrometry
Protein from three pull-down experiments was pooled. Samples were diluted in 400 µL buffer
UA (8 M urea, 100 mM Tris pH 8.5) and concentrated with Amicon Ultra 10 kD filter two times.
100 µL of 50 mM iodoacetamide in buffer UA was added to each sample and incubated five
minutes in the dark. Samples were diluted in 300 µL buffer UB (8 M urea, 100 mM Tris pH 8)
and concentrated with Amicon Ultra 10 kD filter three times. Buffer-exchanged samples were
stored at -80oC until mass spectrometry analysis. Proteins were in-solution digested with trypsin
after reduction with dithiothreitol and alkylation with iodoacetamide. Samples were desalted on a
C18 ziptip prior to LC/MS analysis, which was acquired on an AB SCIEX 5600 nano-LC/MS
system in data-dependent acquisition mode. Peptides were identified using MASCOT by
MS/MS database searching against the UniProt mouse reference database with fixed
carbamidomethyl and variable methionine oxidation modifications. Mascot results were loaded
into Scaffold for protein grouping after filtering for peptides with a 1% FDR and requiring 2
peptides detected per protein. Total spectral counts were used for spectral counting. Proteins
with a minimum of 2 (whole cell) or 5 (subcellular compartment) peptides and a 2:1 ratio of
peptides in the antisense versus sense pull-down were considered enriched. Whole cell pulldowns were performed in duplicate. LC/MS data acquisition and protein identification were
performed in collaboration with Dr. Jason Held.

Western blot
Proteins from cell lysates or pull-downs were separated by gel electrophoresis on 10% sodium
dodecyl sulfate-polyacrylamide gel and transferred to nitrocellulose membrane (Whatman) by
semi-dry method. Membranes were blocked with Relia-blot Blocking reagent (Bethyl) or 1%
BSA (Sigma) in TBST overnight and probed with primary antibodies to fibrillarin (1:1000,
Bethyl), Nop56 (1:3000, Bethyl), hnRNP A1 (1:3000, Abcam), hsp90 (1:750, Enzo/Stressgen),
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nucleophosmin (1:1000, Abcam), histone H3 (1:5000, Abcam), hnRNP U (1:1000, Abcam),
KHSRP (1:1500, Bethyl), Caprin-1 (1:1000, Protein Tech/Fisher), or G3bp1 (1:750, Abcam) for
2 hours at room temperature. Membranes were incubated with appropriate secondary
antibodies (1:10,000, Jackson ImmunoResearch Laboratories) conjugated to horseradish
peroxidase (HRP) for 1 hour at room temperature, then proteins were visualized with Western
Lightning-Plus chemiluminescence substrate (PerkinElmer Life Sciences) on a BioRad
ChemiDoc XRS+ imaging system.

Protein Visualization
Proteins from pull-downs were separated by gel electrophoresis on 10% sodium dodecyl
sulfate-polyacrylamide gel. Gels were fixed for 2 hours in 7% acetic acid/10% methanol, washed
three times in 10% methanol for 20 minutes each, stained for 90 minutes with SYPRO Ruby
(Life Technologies), and washed once with 10% methanol for 20 minutes. Proteins were
visualized on a BioRad ChemiDox XRS+ imaging system.

Immunoprecipitation
Proteins were immunoprecipitated from cytoplasmic lysates generated by Dounce
homogenization in TNEN as above. Lysates were precleared for 15 minutes with protein
A:agarose (Roche), incubated with 1-2 µg of same antibodies used for western blot for 2 hours,
then incubated with 1/10th volume protein A:agarose for 45 minutes, at 4oC with rotating. Beads
were washed three times with 1 mL cold TNEN and once with 1 mL cold PBS. RNA was
collected from 40% of beads with TRIzol. Protein was collected from remainder of beads with
Laemmli sample buffer.

RNA Stability Analysis
Cells were pulsed with 0.3 µM ethynyl uridine for 2 hours at 37oC. Cells were then treated with
palmitate:BSA or vehicle as above during chase in media lacking ethynyl uridine. Total RNA
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was collected with TRIzol immediately after ethynyl uridine pulse or after chase. RNA was
biotin-labeled via click reaction, and labeled RNA was isolated with streptavidin magnetic beads
using Click-It Nascent RNA Capture Kit (Life Technologies) per manufacturer’s instructions.
Labeled RNA was quantified by RTqPCR and normalized to 18S rRNA.

RNA-seq and RPF-seq
Cells were treated with palmitate or vehicle for 8h as above. For RNA-seq, total RNA was
isolated with TRIzol. Ribosomal RNA was removed by Ribo-Zero as part of cDNA library
preparation by the Genome Technology Access Center (GTAC) at Washington University
School of Medicine. For ribosome footprint (RPF)-seq, samples were prepared as previously
described.139 Briefly, cells were lysed in buffer containing 1% Triton X-100 and 100 µM
cycloheximide to stall ribosomes. Unprotected RNA was digested with RNase I (Life
Technologies). Ribosomes and protected RNA were pelleted. RNA was extracted from pellets
with miR-Vana RNA Isolation Kit (Life Technologies). 3’-linker was ligated to footprints and RNA
was reverse transcribed. Ribosomal cDNA was removed by subtractive hybridization with
biotinylated antisense oligos directed against 5.8S, 18S, and 28S and captured with magnetic
streptavidin beads. PCR amplified libraries were sequenced by GTAC. Raw reads were preprocessed with the FASTX toolkit to trim low quality regions or linkers and ribosomal RNA
sequences removed by alignment with Bowtie2 to the Silva mouse rRNA database.166-168
Processed reads were then aligned to the Ensembl R73 mouse genome using Tophat.169,170
Individual reads were mapped to genes using htseq-count to produce counts of total aligned
reads for each gene in each sample.171 DESeq2 analysis was used to identify transcripts
differentially represented in palmitate- and vehicle-treated samples based on differences in
normalized gene counts.172 Computational analysis was performed in collaboration with Dr. Brett
Olsen and Dr. Daniel Ory.
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Gene Ontology (GO) Analysis
Gene lists were generated containing all significantly up-regulated genes, all significantly downregulated genes, and all significantly differentially expressed genes identified by mRNA-seq as
analyzed by DESeq2. GO term enrichment was assessed for each gene list using the Database
for Annotation, Visualization, and Integrated Discovery (DAVID) 6.7.124,125 All gene lists were
compared to a custom background gene list (n=18,852) of genes detected by mRNA-seq.

Gene Set Enrichment Analysis (GSEA)
One custom gene set was created for each of seven AU-rich element consensus sequences,
using lists downloaded from ARE 1.0 (http://rna.tbi.univie.ac.at/cgi-bin/AREsite.cgi).133 The
expression dataset contained normalized mRNA-seq data as fragments per kilobase of
transcript per million mapped reads (FPKM) from two palmitate-treated and two vehicle-treated
samples. GSEA was run with 10,000 gene-set permutations to generate a KolmorgovorSmirnov type statistic measuring enrichment of gene sets up-regulated by palmitate treatment
relative to vehicle.135,136

Calculating Translational Efficiency
We modeled the read counts for each gene as a discrete random variable drawn from a distinct
negative binomial distribution for each sample and gene. The mean parameters were modeled
as the product of a sample-specific size-factor and a condition and method-dependent genespecific expression factor and estimated as described elsewhere.142 Dispersion parameters
were estimated using a maximum a posteriori approach for each condition and method (RNAseq or RPF-seq) using an adjusted fixed-point method173 with an exponential prior
distribution.174 Translation efficiency was estimated for each gene and condition as the biascorrected ratio of expression factors for footprint to RNA-seq data. P-values testing against the
null hypothesis of no difference in translation efficiency between control and palmitate samples
were estimated as the tail probabilities of the joint probability distribution over count sums for
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each method and condition using a pooled translation efficiency parameter and adjusted for
multiple hypothesis testing using a Benjamini-Hochberg correction with 5% false discovery
rate.175 Translation efficiency analysis was performed in collaboration with Dr. Brett Olsen and
Dr. Daniel Ory.
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Table 5.1 Primer and oligonucleotide sequences

Table 5.1 Primer and oligonucleotide sequences
Application

Primer/Oligo

RNase H Assay U33 ASO 1-15

Reverse
Transcription

qPCR

snoRNP
Isolation

ribosomal
cDNA
subtractive
hybridization

Sequence
5’- TCTCATCACAAGCTG-3’

U33 ASO 15-29
U33 ASO 29-43
U33 ASO 43-57
U33 ASO 57-71
U33 ASO 69-83

5’- ATGAGTGGGAGATGT-3’
5’-CGAGCAACTCGAACA-3’
5’- AGTCATCTCATAGTC-3’
5’-GGTAGTGCATGTAGA-3’
5’-ACAGCCTCAGATGGT-3’

mU17b SLRT1

5′-GCGTGGTCCCGACCACCACAGCCGCCACGA CCACGCTTTTGT-3ʹ

mU20 SLRT1

5'-GCGTGGTCCCGACCACCACAGCCGCCACGA CCACGCCTGGAT-3'

mU32a_SLRT1
mU33_SLRT1
mU34_SLRT1
mU35a_SLRT1

5’-GCGTGGTCCCGACCACCACAGCCGCCACGAC CACGCCGAGTCTC-3’
5'-GCGTGGTCCCGACCACCACAGCCGCCACGAC CACGCACAGCCTC-3’
5'-GCGTGGTCCCGACCACCACAGCCGCCACGA CCACGCAGCGTCTC-3’
5'-GCGTGGTCCCGACCACCACAGCCGCCACGA CCACGCTCCTGGCA-3’

Glu tRNA SLRT2

5'-CTCAGCGGCTGTCGTGGACTGGGTGCTGCC
GCTGAGTGGTTCCCTGA-3’

U6 RT
m364B F1
m364B R1
18S F
18S R
Stem Loop Universal R1
mU20 F
mU32a_F1
mU33_F1
mU34_F1
mU35a_F1
U6 F1
U6 R1
mU17b F
mU33 ASO dual biotin

5’-AAT ATG GAA CGC TTC ACG AAT-3’
5’-ATC CCT GAC GCA CCG CCG TGA-3’
5’-TGC ATC TGC TTG GAG CCC ACG TT-3’
5'-ACG GAC AGG ATT GAC AGA TTG-3'
5'-ATG CAC CAC CAC CCA CG-3'
5'-TCC CGA CCA CCA CAG CC-3'
5'-TGGATATGATGACTGATTACCTG-3'
5’-GAGTCCATGATCAGCAACACTCACC-3’
5’-AGCTTGTGATGAGACATCTCCCACT-3’
5’-CGTCTGTGATGTTCTGCTATTACCTACATTGTT-3’
5'-GGCACATGATGTTCTTATTCTCACGATGGT-3'
5'-GCT TCG GCA GCA CAT ATA CTA-3'
5'-CGAATTTGCGTGTCATCCTTG-3'
5ʹ- AACGGGAGCTTAGGGCATT-3ʹ
5'-/5BiosG/mUmGmGmUmAmGmUmGmCmAm
UmGmUmAmGmAmGmUmCmA/3Bio/-3'

mU33 sense dual biotin

5'-/5BiosG/mUmGmAmCmUmCmUmAmCmAmUm
GmCmAmCmUmAmCmCmA/3Bio/-3'

SubHyb 1 18S

5'-/5BioTEG/GGGGGGATGCGTGCATTTATCAGATCA-3'

SubHyb 2 18S
SubHyb 3 18S
SubHyb 4 28S
SubHyb 5 28S
SubHyb 6 28S

5'-/5BioTEG/TTGGTGACTCTAGATAACCTCGGGCCGATCGCACG-3'
5'-/5BioTEG/GAGCCGCCTGGATACCGCAGCTAGGAATAA TGGAAT-3'
5'-/5BioTEG/TCGTGGGGGGCCCAAGTCCTTCTGATCGAGG CCC-3'
5'-/5BioTEG/GCTTTCGCCGAATCCCGGGGCCGAGGAAG CCA-3'
5'-/5BioTEG/GGGGCCGGGCCGCCCCTCCCACGGCGCG-3'
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SubHyb 8 28S

5'-/5BioTEG/CCCAGTGCGCCCCGGGCGTCGTCGCGCCG
TCGGGTCCCGGG-3'

SubHyb 9 28S
SubHyb 10 28S
SubHyb 11 28S
SubHyb 13 28S
SubHyb 14 5.8S

5'-/5BioTEG/TCCGCCGAGGGCGCACCACCGGCCCGTCTC GCC-3'
5'-/5BioTEG/AGGGGCTCTCGCTTCTGGCGCCAAGCGT-3'
5'-/5BioTEG/GAGCCTCGGTTGGCCCCGGATAGCCGGGT CCCCGT-3'
5'-/5BioTEG/TCGCTGCGATCTATTGAAAGTCAGCCCTCGAC ACA-3'
5'-/5BioTEG/TCCTCCCGGGGCTACGCCTGTCTGAGCGTC GCT-3'
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